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ABSTRACT
A series of experiments were designed to determine the cyclooxygenase (COX)
isoform responsible for prostaglandin release during ovulation and luteolysis. Initially,
a reliable, serum-free culture system was developed to produce large numbers of bovine
granulosa cells originally harvested from the small antral follicles of abattoir ovaries.
This method allowed adequate numbers of cells to be obtained for the subsequent study
involving cyclooxygenase regulation.
In a second experiment, bovine granulosa cells from small antral follicles were
isolated and cultured, as in the first experiment for 6 days. Granulosa cells were then
exposed to medium alone or medium containing arachidonic acid (10 nM arachidonic
acid) or forskolin (10 uM). Bovine granulosa cells were capable of being induced into
secreting elevated concentrations of prostaglandins following exposure to forskolin, in
a manner similar to preovulatory granulosa cells stimulated in vivo. Prostaglandin
formation was inhibited by the addition of hydrocorticosterone to the medium,
implicating the COX-2 isoform as being responsible for this prostaglandin formation.
Also, data from a third experiment revealed the presence of COX-2 in the granulosa
cells of women previously stimulated with FSH.
A fourth experiment was performed to determine if dexamethasone regulates COX
formation in the bovine uterus during luteolysis.

Plasma estradiol concentrations

indicated that daily administration of dexamethasone (days 13-22) during the estrous cycle
resulted in an inhibition of follicle development. Although luteal regression occurred at
xi
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the normal time in these animals, uterine biopsies on days 16, 19 and 22 of the cycle and
western blot analysis revealed that COX-2 was not produced by the uterine endometrium
at any of these times.
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INTRODUCTION
It is astonishing to reflect upon the accuracy of early reports involving
mammalian reproductive processes. It has been over 70 years since the first reports
implicated the uterus in luteolysis. After determining that hysterectomizing guinea pigs
resulted in an extension of the estrous cycle, Loeb (1927) concluded "it is possible that
the uterus, in particular its mucosa, produces an internal secretion which exerts a
specific, abbreviating effect on the life of the corpus luteum". Since this earlier report,
the uterus has been shown to regulate the functional lifespan of the corpus luteum in
common farm animal species including the pig (Moeljono et al., 1976), the sheep
(Wiltbank, 1966) and the cow (Malven and Hansel, 1964).
Today, it is accepted by most that the luteolytic hormone in ruminants is
prostaglandin F2a. It is also accepted that luteolysis is a local process, involving the
veno arterial transfer of prostaglandin from uterine vein to the ovarian artery (Hixon
and Hansel, 1974). The mechanism by which uterine prostaglandin travels to the ovary
has been termed the luteolytic counter-current transfer (McCracken et al., 1972).
However, the manner in which prostaglandin F2a induces luteolysis, once traversed to
the corpus luteum, remains controversial (Goldberg and Ramwell, 1975; Hansel and
Convey, 1983).
The scope of prostaglandin study has broadened from the initial studies on its
role as a luteolysin to other reproductive processes. Although not fully understood, the
mechanisms by which prostaglandins induce ovulation are currently undergoing intense
1
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scrutiny. Espey (1980) hypothesized a general model for mammalian ovulation that
included the accumulation of prostaglandins in the follicular fluid of preovulatory
follicles. The process of ovulation was compared to that of inflammation, where
prostaglandins were believed to perform many of the same actions. Some of these
actions include activating quiescent fibroblasts, serine proteases and collagenase,
causing an overt destruction of the follicle wall.
The enzyme responsible for the majority of prostaglandin production is the
cyclooxygenase (COX) enzyme (Sigal, 1991). It is a rate limiting step in the formation
of all types of prostaglandins, including prostaglandins

I2 and F2a, or those familiar

to scientists in the field of reproductive physiology. Recently, research has unveiled
a new isoform of the COX enzyme (Rosen et al., 1989). The original isoform (COX-1)
and the newly discovered isoform (COX-2), perform different biological functions that
will be discussed in detail later in this review. Also, the COX-2 isozyme is inducible
and is regulated differently than the original isoform first isolated from sheep vesicular
glands (Miyamoto et al., 1976). The two major classifications of cyclooxygenase
regulatory agents are those of nonsteroidal and steroidal origin, with each having
distinct actions on either isoform.
The studies reported herein were undertaken at the St. Gabriel Louisiana State
University Agricultural Research Station and at The Pennington Biomedical Center in
Baton Rouge, Louisiana.

The experiments were conducted 1) to determine the

feasibility of producing an in vitro bovine granulosa cell serum-free culture system to
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better understand COX activity in these cells, 2) to determine the effects of
dexamethasone on prostaglandin formation by in vitro-cultured bovine granulosa cells
and 3) to determine the origin and function COX-2 during the luteolytic process in
cattle.
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LITERATURE REVIEW
The discovery of a novel COX isoform raised many questions regarding its
function and regulation. The COX-2 isozyme, which is capable of producing large
amounts of prostaglandin upon stimulation (Dewitt et al., 1993), has become an object
of interest to scientists involved in the field of reproductive physiology. Some of the
characteristics of the COX-2 isozyme suggest its involvement in reproductive processes,
such as ovulation and luteolysis, both of which require the rapid elevation of
prostaglandin formation.
This review will be directed toward understanding prostaglandin synthesis, and
the function of prostaglandins in the ovulatory process. The regulation of each COX
isoform will also be discussed, with the major emphasis on steroidal regulation of the
COX isozymes. Finally, the effects of glucocorticoid administration to laboratory and
large animals on estrous cycle events will be reviewed.
Arachidonic Acid Metabolism and Prostaglandin Formation
In the early 1930s, it was noted that human semen and seminal vesicle extracts
caused uterine tissue to contract and relax (Hadley, 1992).

This active purified

substance, prostaglandin, was subsequently isolated from sheep vesicular glands in the
mid 1970s (Miyamoto et al., 1976). Prostaglandins belong to the ecosanoid family of
chemically related substances that also includes: leukotrienes, prostacyclin and
thromboxane (Toh et al., 1992). Since this initial discovery, prostaglandins have been
shown to be intricately involved in a number of biological processes. Some of these
4
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processes include tissue remodeling (Cromwell, 1988; Zurier, 1988), vascular
homeostasis (Weksler et al., 1982), immune cell function (Jonat et al., 1990) and
reproduction (Hixon and Hansel, 1974; Sirois et al., 1992).
The metabolic process from which prostaglandins are derived has been termed
the "arachidonic acid cascade" (Toh et al., 1992). All prostaglandins are variants of
a basic 20-carbon, bilayared molecule (arachidonic acid). This 20-carbon fatty acid is
made available to the organism as a component of the diet (nonruminants) or
synthesized in the liver from linoleic acid (ruminants) and stored in the cells as a
component of the phospholipid bilayer of the cell membrane. In order to become
available to the cell for metabolism, arachidonic acid must be freed from the cell
membrane by the enzyme phospholipase A2, after which it is then converted to
prostaglandins via the COX enzyme (Sigal, 1991).
Although two major routes of arachidonic acid metabolism have been defined,
the COX and lipoxygenase pathways (Murdoch et al., 1993), this discussion will be
concerned only with the COX pathway that involves prostaglandin formation. Figure
1 illustrates an overview of arachidonic acid metabolism. The COX enzyme performs
two functions in the conversion of arachidonic acid to prostaglandin (Sigal, 1991).
Once arachidonic acid is liberated from the cell membrane, COX initially performs an
oxidative function by introducing two molecules of oxygen to form Prostaglandin G2.
Prostaglandin G2 then undergoes a reduction, or peroxidase reaction, to form
prostaglandin H2.
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Figure 1. A schematic drawing of arachidonic acid metabolism to prostaglandin (adapted from Sigal, 1991)
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From this point, prostaglandin H2 is further reduced to other metabolites that are more
familiar in the study of reproductive physiology, including prostaglandin EU, I2 and F2«
(Sigal, 1991).
Recent Discoveries in COX Metabolism
Until the late 1980s, it was assumed that there was only one gene encoding the
COX enzyme (DeWitt and Smith, 1988). The COX enzyme was first isolated from
sheep vesicular glands, and has been the focus of many of the prostaglandin regulatory
studies conducted during the past 15 years (Miyamoto et al., 1976; Hedin et al., 1987).
This original isoform, termed COX-1 in the scientific literature, is translated from a 2.8
kb mRNA transcript and has a mw of 69,000 and 70,000 in the mouse (Hedin et al.,
1987) and bovine species (Sirois, 1994), respectively. Also, the primary structure of
the COX-1 enzyme (8,11,14-icosatrienoate, hydrogen-donor:oxygen oxidoreductase,
EC 1.14.99.1) has been reported (DeWitt and Smith, 1988). However, recent studies
have established the presence of another pharmacologically distinct, but related, isoform
of the original COX enzyme (Kujubu et al., 1987; Rosen et al., 1989).
Rosen et al. (1989) described the transcription of a novel cyclooxygenase
isoform by in vitro-cultured sheep tracheal mucosal cells.

A 70,000 mw cyclo

oxygenase protein and corresponding 2.8 kb mRNA were coordinately expressed, but
the levels did not increase proportionately to the increase in COX activity. However,
rehybridization of Northern blots revealed the presence of a new tissue-specific 4.0 kb
mRNA that exhibited increased expression during in vitro culture.

The authors
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suggested that the novel protein's relatedness to COX and its increased parallel
enzymatic activity further suggest that the larger mRNA may encode for a second COX
protein.
Recent reports have provided direct evidence of the existence of a distinct COX
isoform that is derived from a unique mRNA transcript (Kujubu et al., 1991). It has
been noted that the gene encoding the COX-2 isoform is the U S 10 primary response
gene (Kujubu et al., 1991), which has been cloned (O'Bannion et al., 1992). This gene
was the first primary response gene for which cell-type restricted expression has been
reported (Kujubu et al., 1987). Cyclooxygenase-2 mRNA production was initially
reported to occur following forskolin stimulation of Swiss 3T3 cells that were
previously transfected with the TIS10 gene (Kujubu et al., 1991). This second COX
isoform is translated from a 4.0 kb mRNA and has a molecular weight of 72,000 to
74,000 (Sirois and Richards, 1992).
Although pharmacologically distinct, the COX-1 and -2 isoforms have a
homology of greater than 60% to one another (Kujubu et al., 1991). More importantly,
the amino acid residues believed to be important for catalysis are identical, and each
isoform has the same affinity for and capacity to convert arachidonic acid to
prostaglandin H2. One major difference between the two isozymes appears to be their
dissimilar expression.
The proposed biological roles of each COX isoform have been compiled (see
review by DeWitt et al., 1993) and are presented in Table 1. The COX-1 isoform is
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a constituetively expressed enzyme that is present in most mammalian cells, although
the level of expression does vary between cell types (Kujubu et al., 1991). In contrast,
COX-2 is undetectable in most tissues under normal physiological conditions, but its
expression can dramatically increase during periods of inflammation or mitogenic
stimulation (Kujubu et al., 1993). Many mammalian cell types can be stimulated to
produce the COX-2 isozyme by a variety of compounds including serum (Mitchell and
Trautman,

1993), lippopolysaccharide (Lee et al.,

1992), human chorionic

gonadotropin (hCG; Sirois and Richards, 1992; Sirois et al., 1992; Sirois, 1994),
platelet-derived growth factor (O'Bannion et al., 1992) and forskolin and phorbol esters
(Kujubu et al., 1991).
Another notable difference in the characterization of the two COX isoforms is
their reaction kinetics. Because the COX-1 isoform is constituetively expressed in most
tissues, it has been termed a "housekeeping gene product" that regulates normal cellular
processes, such as kidney function and vascular homeostasis (Jonat et al., 1990).
Conversely, COX-2 has been grouped in the immediate early gene family, by virtue of
its ability to rapidly produce high concentrations of prostaglandins during situations
such as inflammation (Ryseck et al., 1992) and ovulation (Sirois and Richards, 1992;
Sirois, 1994). This characteristic differentiates the COX-2 isoform from the original
COX-1 cyclooxygenase enzyme. The COX-2 isoform has been determined to increase
prostaglandin formation as much as 10- to 80-fold following stimulation (Simonson et
al., 1991).
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Table 1. A compilation of characteristics assigned to the COX-1 and -2 isozymes including: homology, expression, range of
expression, tissue expression regulation and proposed biological activity._________________________________________
Parameter
Homology

COX-1
Similar to COX-2 (>60%)

COX-2
Similar to COX-1 (>60%)

Expression

Constitutive

Inducible

Range of expression

Can increase 2 to 4 fold
following stimulation

Can increase 10 to 80 fold
following stimulation

Platelets, endothelial cells,
fibroblasts, stomach,
kidneys, smooth muscle
most tissues

Prostate, brain, activated monocytes or
synoviotes during inflammation, follicles
preceding ovulation

Little to none

Inhibits expression

"Housekeeping" gene; produces
prostaglandins that regulate normal
kidney and gastric function and
vascular homeostasis

"Inflammatory response gene"; produces
prostaglandins involved in inflammation
"Immediate early gene"; controls
mitogenesis, produces prostaglandins
involved in cell growth and ovulation
(adapted from DeWitt et al., 1993)

Major tissues expressing
each isoform

Effect of
glucocorticoids
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The rapid generation and degradation of the COX-2 isozyme within a tissue
makes it a logical candidate for being the paracrine factor that allows adjacent cells to
relay information to each other (Murdoch et al., 1993). The rapid activation of genes
whose products (COX-1 and -2) are responsible for prostaglandin synthesis in
endotoxin-stimulated macrophages (Lee et al., 1992), may represent an important
mechanism by which stimulated cells signal their neighbors of their impending division.
This mechanism lends credence to the hypothesis that prostaglandin accumulation in
preovulatory follicles is responsible for the cascade of events that occur following the
rapid activation of quiescent fibroblasts.

This process ultimately culminates in

ovulation, and release of the oocyte from the dominant follicle into the oviduct for
fertilization (Espey, 1980).
In summary, the COX enzyme plays an essential role in the conversion of
arachidonic acid to prostaglandin in the process known as the "arachidonic acid
cascade". This enzyme is essential to prostaglandin formation, and performs rate
limiting actions in the conversion of arachidonic acid to prostaglandin G2 and H2. In
turn, these prostaglandins are converted to other isoforms. It has been determined that
two isoforms of the COX enzyme exist (Kujubu et al., 1991). Both isoforms are
produced by a variety of tissues in the body; however, each isoform performs different
biological functions. With the general function of each isoform fairly well defined,
understanding the regulatory mechanisms of each isoform has now become the focus
of research efforts.
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Induction of COX Activity During Mammalian Ovulation
Until now, this review has focused on COX-2 formation during inflammation.
Recent studies have implicated prostaglandins in mammalian ovulation, which has
previously been compared with an inflammatory response (Espey, 1980).

This

hypothesis has recently been updated (Espey, 1994). This basic model for ovulation
in mammals is summarized in Figure 2. Breifly, prostaglandins are responsible for
activating quiescent fibroblasts, which then activate serine proteases. Collagenase is
then believed to be responsible for the degradation of the collagen fibres in the
preovulatory follicle wall, resulting in ovulation. This process was hypothesized to be
triggered by the preovulatory surge in LH.
The LH surge has since been shown to induce COX activity in rat preovulatory
follicles (Hedin et al., 1987). A 72,000 mw COX protein was induced by mural
granulosa cells following human chorionic gonadotropin (hCG) administration. The
protein was produced by mural granulosa cells of preovulatory follicles 5 to 7 hours
following exogenous administration of 10 IU hCG.

Its production was shown to

continue in increasing amounts until the time of expected ovulation. However, rat
corpora lutea isolated 24 hours following hCG administration did not contain this novel
72,000 mw protein. Although the molecular weight of this COX enzyme was greater
than that noted to be the case of the original rat isoform (72,000 vs. 70,000 mw,
respectively), no mention of the possibility of this being a novel isoform was made in
the latter study (Hedin et al., 1987).
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Figure 2. A schematic presentation summarizing prostaglandin activity
during mammalian ovulation (adapted from Espey, 1980).
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Building on these data, an in vivo and in vitro study performed by Sirois et al.
(1992) described the presence of the novel COX mRNA in rat preovulatory follicles.
For the in vivo portion of the study, hypophysectomized, immature female rats were
administered estradiol-176 (1.5 mg/day for 3 days) and FSH (1

for 2 days). Follicles

were isolated from donor ovaries each hour for 11 hours following administration of
an ovulatory dose of hCG. A similar experiment was performed in vitro, with donor
follicles collected immediately following hCG administration, which were later
evaluated for COX-2 mRNA and protein production during the same time frame as the
in vivo portion of the study.
Results from the Northern blot analysis indicated that the COX-2 isoform is
induced by hCG. Production of the 4.4 kb mRNA that translates the COX-2 isoform
was noted to be rapid and transient, with concentrations increasing from an undetectable
level at 0 hour and reaching maximal concentrations 4 hours post hCG stimulation.
Levels of COX-2 mRNA were again undetectable at the 6 through 11 hour sampling
periods. Western blot analysis, using an antibody which recognizes both isoforms,
demonstrated that the actual COX-2 protein was translated 4 hours following in vivo
administration of hCG and was continually produced throughout the sampling period.
A similar trend in COX-2 mRNA and protein production was noted in the in vitro study
(Sirois et al., 1992).
A study performed by the same authors was designed to determine the follicle
cell type responsible for producing the COX-2 isoform (Sirois and Richards, 1992).
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Follicles were harvested from hypophysectomized rats that were estrogen primed as
previously described (Sirois et al., 1992). The follicles were then dissected to isolate
the granulosa cell layer from the rest of the follicle tissue. Western blot analysis
indicated that the COX-2 isoform was selectively induced in granulosa cells, while
being absent in residual follicle tissue, which included the membrane granulosa and
theca cells. Also, a 59,000 mw gel band was reported, and assumed to be a breakdown
product of the COX-2 isoform.
The most recently published study pertaining to COX-2 production in
preovulatory follicles was performed in cattle (Sirois, 1994). Holstein heifers were
administered 25 mg of prostaglandin F2a on day 7 of the estrous cycle to induce corpus
luteum regression. An ovulatory dose of hCG (3,000 IU) was administered 36 hours
following the prostaglandin injection. Ovaries were collected at 6 hour intervals for 18
hours, then every 2 hours until 26 hours post-hCG injection. The cells of whole
preovulatory follicles produced COX-2 beginning at 20 hours post-hCG. Following
isolation of granulosa cells and theca interna cells from the follicle, it was found that
COX-2 was exclusively produced in granulosa cells. No detectable levels of COX-2
were produced by the theca interna cells.

Also, increasing concentrations of

prostaglandin F2a were released into the follicular fluid 22 through 26 hours following
hCG administration.
The purification and identification of COX-2 in hCG induced rat and bovine
follicles represents an important step toward understanding the role of prostaglandins
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in the biological process of ovulation. The selective localization of COX-2 in the
granulosa cells of preovulatory follicles and its transient expression following the
LH/hCG surge, indicate that the regulation of COX-2 is under stringent transcriptional
control. Moreover, the acute induction of COX-2 by gonadotropins in granulosa cells
before ovulation is a unique biological event, which may allow molecular mechanisms
of COX-2 to be studied in vivo and in vitro.
Differential Regulation of COX Metabolism
The understanding of COX regulatory mechanisms has improved since the
discovery of the novel COX isoform. It is now known that certain compounds are
capable of specifically inhibiting catalysis of arachidonic acid by either or both
isoforms.

These regulatory agents have been subdivided into two major groups

including nonsteroidal and steroidal inhibitors of COX formation ( Dewitt et al., 1993).
A variety of nonsteroidal anti-inflammatory agents have been researched, while the
major steroidal agent investigated to date has been cortisol and related synthetics
(Mitchell and Trautman, 1993).
Nonsteroidal Regulation
The oxidative function of COX is the target site of aspirin and other non
steroidal anti-inflammatory drugs (NSALD), which are considered to be competitive
inhibitors of COX-1 (Vane, 1971). DeWitt and Smith (1988) have demonstrated that
aspirin inhibits the oxidative function of COX via irreversible acetylation of the "active
site" serine residue at position 530. Mizuno et al. (1982) compared the effects of

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

various anti-inflammatory drugs on the oxidative and peroxidase activity of the COX
enzyme. It was determined that several NSAID including: aspirin, indomethacin,
flurbiprofen and sulindac sulfide inhibited the oxidative activity of COX. However,
other nonsteroidal agents, such as phenylbutazone and BW755c have been shown to
inhibit the peroxidase activity of COX.
Meade et al. (1993) designed an experiment to determine if NSAID inhibit
COX-2 production, and to determine if these agents possess any selectivity towards one
specific isozyme. Cos-1 cells were transfected with cDNA for both COX-1 and-2 and
incubated in medium with or without indomethacin or aspirin. Results of this study
indicated that both aspirin and indomethacin specifically inhibited COX-1 activity,
without affecting the production of COX-2.
Further investigation into NSAID has revealed preferential selectivity between
the COX-1 and -2 isozymes (Meade, 1992). As earlier reported (Meade et al., 1993),
sulindac sulfide specifically inhibited COX-1 production by Cos-1 transfected cells.
However, the NSAID 6-methoxy-2-naphthylacetic acid, selectively inhibited COX-2
production. Another NSAID ibuprofen was found to inhibit both isoforms equally.
In summary, NSAID are capable of selectively inhibiting either or both of the
COX isoforms. In the future, it is possible that in vivo administration of NSAID that
are capable of selectively inhibiting COX-2 production, may be found to spare the
"housekeeping" activity of somatic cells, while reducing inflammation. Since COX-2
is the isozyme responsible for prostaglandin formation in the preovulatory follicle, it
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is also interesting to speculate the possible role these NSAID could play as a method
of birth control.
Steroidal Regulation
Since initial reports focused on the original COX isoform, hormonal regulatory
studies involving glucocorticoids were often contradictory. Dexamethasone (9-flouro11, 17, 21-trihydroxy-16 -methylpregna-1, 4-diene-3, 20-dione), is a synthetic corti
costeroid that has been utilized in many COX regulatory studies, provides very potent
glucocorticoid effects in vivo and in vitro. Dexamethasone is similar in structure to
endogenously produced glucocorticoids and, in fact, is produced by modification of
cortisol (Asdell, 1978).
Prior to the characterization of the COX-2 isoform, in vitro studies indicated
that dexamethasone restricted COX formation by inhibiting phospholipase A2, resulting
in a decrease in amount of available arachidonic acid (DiRosa et al., 1984). This idea
was supported by Nasjletti et al. (1984) who noted a decrease in prostaglandin secretion
by rat brain medullary slices that were cultured in medium supplemented with dexam
ethasone. In contrast, when arachidonic acid was added to dexamethasone-supplemented culture medium, prostaglandin secretion was not decreased. These results led the
authors to believe that dexamethasone had decreased prostaglandin formation by
inhibiting phospholipase A2 activity, and subsequent arachidonic acid release from the
cell membrane. However, later studies have challenged the idea that dexamethasone
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inhibits prostaglandin formation at the phospholipase A2 level (Davidson et al., 1987;
Bronnegard et al., 1988).
Although prostaglandins and corticosteroids are known to be active participants
in the inflammatory response, in vivo studies indicated that dexamethasone had no in
vivo inhibitory effects on systemic prostaglandin synthesis (Lewis and Piper, 1975;
Nara-Fejes-Toth et al., 1984). Nasjletti et al. (1984) designed an in vivo experiment
to determine the effects of dexamethasone on urinary excretion and plasma
concentrations of prostaglandins. It was noted that rats administered subcutaneous
injections of dexamethasone did not have reduced concentrations of prostaglandins in
either plasma or urinary excretions. Some experimental animals actually excreted
higher concentrations of prostaglandins in plasma when compared with saline-treated
controls; however, this phenomenon was attributed to a decrease in metabolism rather
than a physiological effect on prostaglandin metabolism.
Nara-Fejes-Toth et al. (1984) reported total body and renal prostaglandin
content following dexamethasone administration by measuring excretory prostaglandin
metabolites. Under normal physiological restraints, rabbits were fed either water alone
cr water containing dexamethasone (1 mg/kg per day) for 7 days, and the urinary
excretions were collected. The administration of dexamethasone failed to cause a
decrease in urinary prostaglandin metabolite production when compared with animals
in the control group. The authors hypothesized this lack in response may be due to the
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fact that the dose of dexamethasone administered was not high enough to provide a
physiological affect.
Interestingly, the authors did note in their discussion that the majority of studies
that were performed to this date that implicated dexamethasone in prostaglandin
inhibition all utilized cells that were stimulated by endotoxins (Blackwell et al., 1980;
Hirata et al., 1980) or injury (Danon and Assouline, 1978). The hypothesis that
dexamethasone regulates prostaglandin production only in stimulated cells launched a
series of experiments involving COX regulation by dexamethasone during the
inflammatory process.
In retrospect, Masferrer et al. (1990) may have unknowingly published one of
the first reports in the scientific literature involving dexamethasone inhibition of COX-2
catalysis.

Male Balb-C mice were divided into one of four groups receiving

intravenous saline, endotoxin (lipopolysacharride, LPS), endotoxin plus dexamethasone
or dexamethasone alone. Peritoneal macrophages were harvested from the mice and
allowed to attach to a 24-well tissue culture plate. It was noted that macrophages
harvested from mice treated with LPS secreted increased levels of prostaglandin Ej and
the prostaglandin I2 metabolite (6-keto PGF,a) when compared with control animals
that received only saline. When LPS and dexamethasone were injected simultaneously,
prostaglandin secretion decreased to control levels. Dexamethasone administration
alone did not affect prostaglandin secretion above or below that of the control
concentrations.
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Still with the knowledge of the existence of only one COX isoform, Masferrer
et al. (1992) performed a classic endocrine study in an attempt to determine the
mechanics of COX regulation by dexamethasone. In order to remove any endogenous
glucocorticoid effect, peritoneal macrophages of adrenalectomized (ADX) mice were
cultured for 2 hours following in vivo administration of saline, LPS, dexamethasone
or LPS plus dexamethasone. Prostaglandin production (6-keto-PGFIa and PGEj) by
the macrophages of ADX mice increased when LPS was administered. As previously
described by Masferrer et al. (1990), in intact mice dexamethasone decreased prosta
glandin formation to control levels. Prostaglandin secretion was also decreased to
control levels following in vitro culture of macrophages simultaneously stimulated with
LPS and dexamethasone.
A similar trend was noted in the production of a protein (COX) with an
approximate molecular weight of 70,000 to 72,000 by LPS-stimulated mouse macro
phages (Masferrer et al., 1990, 1992). Western blot analysis of macrophages harvested
from LPS stimulated intact (Masferrer et al., 1990) or ADX (Masferrer et al., 1992)
mice indicated the production of COX to be greater than from macrophages retrieved
from control (unstimulated) mice.

As with prostaglandin production itself,

dexamethasone decreased this LPS stimulation of COX to levels similar to macrophages
harvested from control mice. Since the initial report by Masferrer et al. (1990),
dexamethasone has been shown to inhibit COX activity in other biological tissues
including human dermal cells (Seibert et al., 1990), bronchial alveolar macrophages
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(O'Sullivan et al., 1993), bovine placenta (Izhar et al., 1992) and mouse uterine stroma
(Jacobs et al., 1994).
Although the COX-2 isoform was not specifically characterized as such in the
studies reviewed so far, it may now be extrapolated from existing data (Masferrer et
al., 1990, 1992) that the decrease in prostaglandin secretion by stimulated mouse
peritoneal macrophages may have actually been a result of the inhibition of COX-2
catalysis. This conclusion may be reached on the basis of the differing kinetics of the
two isoforms.

It is now realized that the COX-2 isoform is activated only upon

stimulation, and is able to produce levels of prostaglandins 10 to 80 times greater than
the COX-1 isoform. Also, these studies indicated that the molecular weight of the
COX isozyme noted in stimulated cells of all species evaluated to date is larger than the
original COX-1 isozyme, which is characteristic of the COX-2 isozyme (Sirois et al.,
1992).
It was not until the early 1990s that the dispute over COX regulation by
dexamethasone was resolved. With identification of the amino acid sequence of COX-2
(Kujubu et al., 1991), Lee et al., 1992 prepared antibody specific to COX-2 by
injecting rabbits with a conjugated amino acid sequence specific to the mouse COX-2
carboxyl terminus. A second polyclonal antibody was prepared against purified ram
seminal vesicle cyclooxygenase. This polyclonal antibody recognized both the COX-1
and COX-2 isoforms, but possessed a preferential affinity for COX-1.
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The antibody specific for COX-2 did not detect COX in ram seminal vesicles
extracts, indicating the majority of COX present was COX-1 (Lee et al.. 1992). An
in vitro comparison of COX-1 and COX-2 by western blot analysis revealed that COX2 was present only in rat macrophages previously stimulated with LPS (10 ^g/ml).
This COX-2 expression was specifically inhibited when dexamethasone (2 mM) was
introduced into the incubation medium. These results indicate that endogenous COX
present in cells prior to LPS stimulation consists mainly of COX-1. Furthermore,
enhanced activity of COX and the subsequent increase in prostaglandin secretion
induced by LPS was due mainly to the selective expression of COX-2 and not due to
increased COX-1 catalysis.
In the same study (Lee et al., 1992), a time course for COX-1 and -2 mRNA
transcription was also determined following LPS stimulation. It was noted that the
majority of mRNA contained in unstimulated rat macrophages was COX-1. However,
when macrophages were stimulated with LPS, the majority of mRNA transcribed was
that of COX-2. It was also noted that the kinetics of the COX-2 mRNA was fairly
rapid, with maximal production occurring 6 hours following LPS stimulation. This
high production of COX-2 mRNA was noted to continue for 24 hours, or the remainder
of the time frame analyzed in this study. These data support those of Kujubu and
Herschman (1992), who reported that dexamethasone directly inhibits TIS10 mRNA
accumulation in transfected Swiss 3T3 cells.
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These results were further investigated to determine dexamethasone regulatory
actions on interleukin-1-induced COX production in vitro (Feng et al., 1993). In this
study, antibodies utilized for western blot analysis were produced in a manner similar
to that reported by Lee et al. (1992), and their specificity determined using cos-7 cells
previously transfected with recombinant rat DNA that transcribed both COX-1 and
COX-2. Western blot analysis indicated that COX-2 is induced by interleukin-1 in
vascular smooth muscle cells; whereas, COX-1 production is not affected.

Also,

dexamethasone was noted to inhibit the transcription of COX-2 mRNA and the
translation of COX-2 itself. Dexamethasone had no effect on COX-1 translation.
Taken together, the studies reported herein and those of others (Raz et al.,
1989: Jacobs et al., 1994), indicate that COX metabolism and regulation is dependant
upon the level of stress imposed on the animal system being evaluated. Stress, either
natural or induced, appears to encourage the production of the COX-2 isozyme. This
isozyme is rapidly induced upon stimulation, and is capable of increasing prostaglandin
production anywhere from 10 to 80 fold (Simonson et al., 1991).

It is these

characteristics that have intrigued scientists in reproductive physiology.

Since

prostaglandins have been implicated in reproductive processes, such as ovulation and
luteolysis, investigations into the role of COX-2 in these processes have been initiated.
Effect of Dexamethasone Administration on Reproductive Cyclic Events
The discovery of a novel, inducible isoform of the cyclooxygenase enzyme has
increased the interest in reproductive processes of large and small animals that require the
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presence of prostaglandin. However, this isoform is stimulated in several biological tissues
by a variety of compounds, including serum constituents (Mitchell and Trautman. 1993).
lippopolysaccharide (Lee et al., 1992), hCG (Sirois and Richards, 1992; Sirois et al.,
1992; Sirois, 1994), platelet derived growth factor (O'Bannion et al., 1992) and
forskolin and phorbol esters (Kujubu et al., 1991). Once stimulated, the COX-2 isoform
is capable of producing prostaglandins at a rate that is 80 times greater than COX-1
(Dewitt et al., 1993)
The majority of research involving COX catalysis in reproduction has focused on
prostaglandin formation during the ovulatory process. It has been determined that the
COX-2 isoform is responsible for the majority of prostaglandin production by rat (Sirois
and Richards, 1992; Sirois et al., 1992) and bovine (Sirois, 1994) granulosa cells
immediatley prior to ovulation. For each of these species, it was noted that COX-2 is
stimulated by the preovulatory LH surge. Time course analyses performed in these studies
have indicated that the production of COX-2 mRNA and protein are necessary for
prostaglandin synthesis in preovulatory follicles. Differences in COX-2 kinetics may be
responsible for the disimilar intervals from LH peak to ovulation observed among species.
Early studies have provided evidence that the luteolytic hormone, prostaglandin
F2a, is responsible for luteolytic process in ruminants. Uterine prostaglandin secretion has
been theorized to be involved in the luteolytic process of sheep (McCracken et al., 1972)
and cattle (Hixon and Hansel, 1974). McCracken et al. (1971) demonstrated that
prostaglandin F2a of uterine origin is transferred from the uterine vein to the ovarian
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artery, where it was then beleived to be responsible for corpus luteum regression. This
model of luteal regression has been termed the counter current mechansism in the
scientifiic literature. These data were supported by Hixon and Hansel (1974) who
reported that sectioning the broad ligament ipsilateral to the corpus luteum resulted in an
extension of the bovine estrous cycle. The fact that exogenous prostaglandin F2a
administration to cows in the luteal phase of the estrous cycle causes luteal regression also
supports the idea that prostaglandins are necessary for luteolysis in ruminants (see review
by Hansel et al., 1973).
These findings lead one to consider that luteolysis in ruminants is a local
mechanism involving the uterus and ipsilateral corpus luteum. However, additional
observations have resulted in contradictory results. Milvae and Hansel (1980) reported
that there is no significant increase in ovarian prostaglandin F2a concentration during
periods when concentrations are high in the uterine vein. Questions also arise due to the
fact that luteal cells themselves are capable of secreting prostaglandins during in vitro
culture, indicating that luteal regression may not require prostaglandin F2a of uterine
origin (Shemesh and Hansel, 1975; Milvae and Hansel, 1983). These findings suggest that
arachidonic acid may be transferred from the uterus in a counter current exchange rather
than prostaglandin F2a.
Various corticosteroids have been shown to adversely effect reproductive
performance in farm animals. Cummings et al. (1980) reported that cattle injected
daily with dexamethasone (30 mg) from the day of estrus (day 0) through day 2 of the
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estrous cycle had no effect on ovulation of estrous cycle length. This phenomenon has
also been reported in cyclic mares (Ellsworth et al.. 1983).

However, when

dexamethasone (30 mg) was administered during the luteal phase of the estrous cycle
(days 13 through 17), the length of the estrous cycle was extended in this study
(Abdalla et al., 1980). Moreover, although estrous cycle length was extended, fertility
of the subsequent estrous cycles were not impaired.
Liptrap and McNally (1976) reported the effects of hydrocortisone on the
ovulatory mechanism of Holstein heifers. The experimental animals were administered
hydrocortisone (1,000 mg/day from days 16 to day 4 of the subsequent estrous cycle)
exhibited delayed ovulation (by 2 days) when compared with saline injected animals.
Ovulation was completely inhibited when ACTH was administered during the same
time period. This decrease in ovulation rate appeared to be caused by an abatement of
LH secretion, since an oVulatory injection of hCG (10,000 IU) restored ovulation rates
to those observed in control animals.
The adverse effects of stress on bovine reproduction have been directly linked
to an inhibition of gonadotropin release from the pituitary. Physical restraint for 15
minutes, twice daily during the follicular phase in cattle prevented the preovulatory
surge in LH (Stoebel and Moberg, 1982b). No delay in the onset of estrus was
observed when ewes were restrained following estradiol administration; however,
when animals were primed with estradiol during restraint, the LH surge was delayed
3 hours.

Confinement induced stress has also been determined to decrease the
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amplitude and frequency of LH secretion in ewes (Rasmussen and Malven, 1983) and
monkeys (Norman and Smith. 1992).
The administration of exogenous cortisol has also been shown to affect pituitary
release of LH. The administration of cortisol to preovulatory staged Holstein heifers
resulted in a prevention of the LH surge in three of four animals (Stoebel and Moberg,
1982a). Similarly, the amplitude and frequency of LH secretion was decreased in
postpartum suckled and nonsuckled beef cows (Dunlap et al., 1981).
Hydrocortisone and dexamethasone have also been demonstrated to affect the
developing corpus luteum. Hereford heifers injected with ACTH (100 IU/day) on days
2 through 8 of the estrous cycle had lower weight corpora lutea at slaughter (day 9)
than did animals administered the vehicle control treatment (Wagner et al., 1972). In
a susequent study, Wagner et al. (1977) demonstrated that ovarian perfusion of ACTH
or hydrocortisone did not affect luteal function. However, carotid infusion on days 2
to 9 of the estrous cycle resulted in a prolonged rise in progesterone production during
the infusion period. No differences were noted in plasma progesterone concentrations
on days 9 to 11 between the treated and control animals.
More recent studies have suggested that the lifespan of the bovine corpus luteum
is extended following ACTH or dexamethasone administration. Pool et al. (1983)
allotted crossbred beef cows to either free pasture or pen confinement and subdivided
these groups into those receiving ACTH (200 IU/day) or vehicle on days 17 through
21 of the estrous cycle. Animals confined to pens exhibited an extended estrous cycle

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

29
length of approximately 2 days when compared with their pasture-housed counterparts.
This extension of the estrous cycle was attributed to increased corpus luteum function
as determined by plasma progesterone. When the data from pen and pasture housed
animals were combined, the interval from progesterone decline to subsequent estrus was
extended an average of 5.5 days. It appears that physical stress and induced stress (i.e.,
ACTH injections) have different physiological effects: physical stress causing increased
corpus luteum lifespan and ACTH stress causing abnormal follicle development.
The same research group reported the effects of dexamethasone administration
on reproductive performance in cattle (Ingraham et al., 1984). Animals were again
assigned to pen or pasture confinement and dexamethasone was administered to cows
allotted to each group on day 16 of the estrous cycle (20 mg/day) and days 17 through
20 (30 mg/day). Interestingly, plasma progesterone and rectal palpation indicated that
half (8 of 16) of the animals receiving dexamethasone had prolonged luteal function.
Plasma progesterone profiles of individual animals indicated that the decline in
progesterone concentration to below 1 ng/ml occured later in some dexamethasone
treated animals when compared with the saline injected controls. Results from the
endocrine profiles were substantiated by rectal palpation of functional corpora lutea.
Vighio and Liptrap (1990) observed some of the same trends of luteal extension
following dexamethasone (2 mg) administration to cattle on days 13 through 17 of the
bovine estrous cycle. Mean progesterone secretion above 1 ng/ml was extended an
average of 10 days. It was also reported by the authors that dexamethasone lessened
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both estrogen and LH secretion. The estrogen surge was abated by dexamethasone, and
the pulsatile release of LH was decreased in amplitude and frequency. These results
suggest that dexamethasone may decrease estrogen secretion; thereby, decreasing
estrogens biphasic effect on gonadotropin release from the pituitary. This decrease may
be adequate to slow follicle development, but maintain corpus luteum function.
Cortisol has also been shown to act directly on bovine granulosa cells of small
follicles (Kawate et al., 1993). Granulosa cells cultured in vitro in medium alone
secreted significantly more estradiol than those cultured in medium containing cortisol
(10

mM).

Similarly, granulosa cells cultured in medium alone possessed a higher

number of LH receptors on the cell membrane than did those cultured in medium
containing cortisiol (. 1 or 10 mM). These data suggest that cortisol suppresses estradiol
production by bovine granulosa cells by decreasing the number of LH receptors
available for recognizing circulating LH.
A further study suggests that dexamethasone has direct effects on the brain
(Pool, 1980). The administration of dexamethasone to cows on days 2 through 5 of the
estrous cycle (20 mg) resulted in a lower number (25%) exhibiting standing estrus
following exogenous estrogen administration. However, 100% of the control animals
that were administered physiological saline exhibited standing estrus. This is in contrast
to a standing estrus response noted in ovariectomized dairy heifers injected with
estrogen (Melampy et al., 1957), which suggests dexamethasone can also act directly
on the central nervous system by altering estrogen sensitivity.
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Summary
It is now apparent that prostaglandins play a vital role in many biological
processes. The literature pertaining to prostaglandin function in reproductive processes
has continued to expand in recent years with the discovery of the novel, inducible form
of COX. However, the role of prostaglandins in reproductive processes requires a
separation of their possible physiological actions from their pharmacological effects.
Although pharmacological effects of prostaglandins are clinically significant, they may
not reflect their true involvement in normal physiological processes.
It appears that stress, either natural or induced, has deleterious effects on
reproduction. Its adverse effects on mammalian ovulation may be considered to be
two-fold. Gonadotropin release is inhibited by chronic stress induction, resulting in
abnormal or slowed follicle development. However, acute stress that occurs just prior
to or during estrus may inhibit ovulation by suppressing prostaglandin formation in the
preovulatory follicle. This mechanism of suppression may be related to cyclooxygenase
acitivity, more specifically, COX-2 activity (Sirois, 1994).
One of the most notable observations as a result of dexamethasone
administration is prolongation of the duration of the estrous cycle due to extended luteal
function (Abdalla et al., 1980; Ingraham et al., 1984; Vighio and Liptrap, 1990).
It is not clear why only some animals exhibit extended luteal function following
dexamethasone administration; however, it has been suggested that animals undergoing
normal luteal regression, do so because the luteolytic mechanism was initiated prior to
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dexamethasone administration (Ingraham et al., 1984; Vighio and Liptrap, 1990).
Dexamethasone may suppress luteolysis in those cows having extended luteal function
by inhibiting cyclooxygenase activity in the uterus (Ingraham et al., 1984; Vighio and
Liptrap, 1990), thereby disrupting the counter current exchange of prostaglandin F2a
from the uterine vein to the ovary artery (Hixon and Hansel, 1974).
To date, the use of live animals for determining the effects of certain drugs
remains the optimal method of obtaining true-to-fact biological conclusions. However,
the use of current in vitro culture techniques may also be employed to gain further
understanding of molecular events that occur during the microprocesses of
reproduction. Tissue culture techniques allow researchers to isolate specific cell types
and determine their function in processes such as ovulation. However, the medium
used in these culture systems should be defined, and should not contain biological
serum as a protein source. This is especially true, since serum alone has been shown
to induce P450 side chain cleavage enzymatic activity in bovine granulosa cells (Skinner
and Osteen, 1988) and bovine granulosa-luteal cells (Meidan et al., 1990). Similarly,
serum constituents have been reported to induce prostaglandin formation by activation
of the COX enzyme (Lee et al., 1992; Feng et al., 1993), thereby masking the effects
of any added regulatory agents.
Therefore, it is of the utmost importance to produce a somatic cell culture
system that would allow for cultivation of small numbers of granulosa cells, without
stimulating catalysis of the enzyme being studied. This type of in vitro culture system
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would aid researchers working with small amounts of tissue by allowing for adequate
numbers of cells to be produced for proper enzymatic studies to be performed. Also,
a more defined culture system would preferably provide a more repeatable method of
cultivation of different cell types, thereby allowing more consistent results to be
obtained over time.
Based on the current knowledge from the scientific literature, a hypothesis was
formulated.

A hypothesis that involved the COX-2 isofom, which rapidly and

transiently produces prostaglandins in large amounts, in reproductive processes. Such
processes as ovulation and luteolysis are believed to require large amounts of
prostaglandin for completion; Therefore, in vitro and in vivo studies were designed to
determine the role and origin of prostaglandin formation during these reproductive
processes.
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CHAPTER I
EFFECT OF MEDIA SUBSTITUTES ON BOVINE MURAL GRANULOSA
CELL FUNCTION AND PROLIFERATION DURING IN VITRO CULTURE
Introduction
In vitro studies involving the culture of granulosa cells have expanded our
knowledge of hormonally regulated follicular enzymes (Orly et al., 1980; Savion et al.,
1981b). To date, the most efficient method of increasing cell numbers in vitro involves
use of serum-supplemented culture medium. However, the interpretation of results for
hormonally-regulated enzymes is often unpredictable or complicated by the addition of
serum to the culture medium (Orly et al., 1980; Erickson, 1983).
Serum contains an undefined composite of hormones, nutrients and growth and
attachment factors necessary for cell maintenance and proliferation (Savion et al.
1981a).

Studies involving the effects of serum supplementation on granulosa cell

function demonstrate that serum constituents alone are capable of inducing
steroidogenesis, while masking the effects of added regulatory agents, such as forskolin
and LH (Savion et al., 1981a; Skinner and Osteen, 1988; Meidan et al., 1990).
A recent attempt to propagate bovine granulosa cells using serum substitutes met
with only limited success (Roberts and Echtemkamp, 1994). However, it has been
determined that the addition of insulin (Channing et al., 1976; Veldhuis et al., 1985;
Langhoutetal., 1991), epidermal growth factor, fibroblastic growth factor, and high-
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density lipids (Savion et al., 1981a) alone, or in combination can maintain cellular
viability or support proliferation at a lower rate compared with serum-supplemented
cultures.
Two experiments were designed to determine the effects of commerciallyprepared serum replacers on in vitro proliferation and progesterone secretion by bovine
granulosa cells during in vitro culture. The primary objective of this study was to
evaluate the ability of serum-free culture systems to promote proliferation of granulosa
cells without inducing steroidogenesis.
Materials and Methods
Culture Medium and Supplements
The basal medium, Dulbecco's modified Eagle medium/Hams F-12 nutrient
mixture (DMEM/F-12; 1:1 vol/vol), and GMS-X* (GMSX; media supplement
containing 1.0 g/L insulin, .67 mg/L sodium selenite, .55 g/L transferrin and .2 g/L
ethanolamine), fetal bovine serum (FBS), penicillin and streptomycin were purchased
from Gibco Laboratories (Grand Island, NY). The SerXtend (SerXtend; containing
FGF, EGF, insulin, BSA, transferrin (pasteurized human), ethanolamine, thioctic acid,
selenium and hydrocortisone (< 50 mg/ml protein) was provided by Irvine Scientific
(Santa Ana, CA). The fatty acid-free BSA (FAF-BSA) was purchased from Sigma
Chemical Co. (St. Louis, MO). A photograph of the medium substitutes used in this
study as recieved by the manufacturer are represented in Figure 1.1.
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Figure 1.1. A photograph of the medium substitutes utilized in Experiment I, which
include from left to right (back) SerXtend, FAF-BSA,GMS-X and (front) FBS.
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Granulosa Cell Isolation
For each experiment in Chapter I, ovaries from mixed breed beef cows were
collected from a local abattoir in warm PBS containing 100 units penicillin and 100
Mg/ml streptomycin (antibiotics) and transferred to the laboratory within 7 hours of
collection. A single cell suspension of granulosa cells was obtained by aspirating 2- to
8-mm follicles using a 20-gauge needle attached to a 10-ml syringe (Langhout et al.,
1991), and follicular aspirates were dispensed into 15-ml polypropylene conical
centrifuge tubes (Figure 1.2).

Approximately 10 to 15 ovaries were required to

perform each replicate, with each ovary possessing 5 to 10 follicles. Tubes containing
the granulosa cells were allowed to stettle at room temperature for 15 minutes to allow
sedimentation of cumulus oocyte complexes and aggregated granulosa cells.
The supernatant was aspirated and the granulosa cells (primarily mural
granulosa) were centrifuged at 200 x g for 10 minutes at 20 °C. Granulosa cells were
then resuspended in 10 ml of basal medium (DMEM/F-12) containing 10% fetal bovine
serum, and antibiotics (seeding medium). The cells were washed by centrifugation
three times to remove follicular fluid and any residual contaminants. Following the
final granulosa cell wash, the cells were resuspended in 10 ml of seeding medium, and
the number of viable (non-stained) cells was determined manually by the use of a
hemocytometer and the trypan blue exclusion method that was adapted from the
previous work of Freshney (1987).
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Figure 1.2. A photograph of the tools utilized to isolate and culture bovine granulosa cells
including the needle and syringe, bovine ovary, tissue culture flasks and conical tube.
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Experiment 1
The objective of Experiment 1 was to develop a defined culture system that
would allow granulosa cell proliferation under serum-free conditions. The efficacies
of two commercially-prepared medium additions to grow granulosa cells were
compared with common medium supplements, FBS and FAF-BSA. For the initial
seeding, 5 x 105 viable cells were placed into duplicate sets of 25-cm2 tissue culture
flasks (5 flasks/treatment/replicate; Costar; Cambridge, MA) containing 5 ml of
seeding medium.

Cells were allowed to attach to the substratum for 48 hours in

seeding medium and then washed once with basal medium. Culture flasks containing
granulosa cells were randomly allotted to the following treatments: basal medium alone
(1), basal medium containing 1 % vol/vol FBS (2), 1 % vol/vol GMS-X (3), 4 mg/ml
FAF-BSA (4), or 5 % vol/vol SerXtend (5). All cultures were maintained at 39 °C in
an atmosphere of 95 % air and 5 % C 02.
On culture days 1, 2, 4, 6 and 8 of treatment culture, the number of granulosa
cells/flask was determined and the culture medium was harvested. At each count,
except days 1 and 8, media were aspirated and replaced with fresh treatment media in
the remaining flasks.
Experiment 2
Based on the results of Experiment 1, two dose respnose trials were conducted
to evaluate different concentrations of SerXtend and different seeding procedures on the
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rate of proliferation of granulosa cells. In the first trial, granulosa cells were initially
seeded in 25-cm2 flasks with 5 x IQ5 cells in seeding medium for 48 hours. Following
the seeding period, treatment media were allotted to duplicate sets of flasks (S
flasks/treatment/replicate). The treatments consisted of basal medium alone (1), or basal
medium containing 5% (2), 2.5% (3), 1.25% (4) or .625% SerXtend (5).
A second dose response trial was carried out to determine if reducing the initial
seeding rate and period would allow adequate cell growth.

Following the initial

viability assessment and count, cells were seeded at 2.5 x 10s cells/25 cm2 flask and
cultured in medium containing 10% serum for 24 hours prior to treatment culture.
Treatment cultures consisted of basal medium (1), or basal medium containing 2.5 %
(2), 1.25 % (3), .625 % (4), .3125 % (5) or .078 % (6) SerXtend. Granulosa cell
counts were determined on days 1, 2, 4, 6 and 8 of treatment culture for each trial and
medium was replaced in the remaining flasks every other day of treatment culture,
except on days 1 and 8.
Determination of Granulosa Cell Numbers and Medium Harvest
At designated intervals for each experiment, the number of granulosa cells in
each flask was determined by removing the cells from the bottom of the culture vessel
using a .05 % trypsin solution containing .2 mg/ml EDTA (Sigma).

During the

trypsinization procedure, flasks were incubated on an incubator/shaker at 39°C for 5
to 10 minutes, or until the cells became rounded and lifted off the substratum. The cell
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suspension was then diluted with seeding medium (1:2 vol/vol) to inactivate the trypsin.
The number of granulosa cells/treatment was determined using a hemacytometer and
cell viability determined by the trypan blue dye exclusion method (Freshney, 1987).
In Experiment 1 and 2, medium was harvested from flasks at each cell count, and
centrifuged at 200 x g for 20 minutes at 20°C for later progesterone assay.
Progesterone Concentration
Progesterone was analyzed in Experiments 1 and 2 using a previously validated
RIA (Thompson et al., 1983). The RIA was performed in duplicate with appropriate
standards. Standards were extracted with petroleum ether prior to RIA analysis. The
progesterone antibody cross reacts with pregnenolone (.5%), estrone (< .01% ),
testosterone (< .01%) and androstenedione (.04%). Media samples were diluted 50fold prior to the assay, with a 50-^1 volume of sample added to each tube. All values
were obtained in a single assay, with an intra-assay coefficient of sl2.5 % with a
percent recovery rate and binding rate of [3H] progesterone of 75% and 38%,
respectively.
Statistical Analysis
For Experiment 1, granulosa cells from each of two groups of ovaries were
randomly divided into two replicates for each treatment and sampling time, with a third
batch of ovaries providing cells for a single replicate (n=5 replicates/treatment/time).
For Experiment 2, two replicates were performed from each of two ovary batches (n=4
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replicates/treatment/time) for each response curve.

Cell counts and progesterone

concentrations were analyzed using least square analysis of variance and the PROC
GLM procedure of SAS (1985). If the differences between treatments were significant,
the PDIFF procedure of SAS was used to the compare means. Data were analyzed
using the model components of ovary batch, treatment, ovary x treatment,
replicate(ovary batch x treatment), time, ovary batch x time, treatment x time, ovary
batch x treatment x time and residual. The effect of ovary batch and ovary batch x
treatment was tested using replicate(ovary batch x treatment) as the error term. The
effect of treatment was tested using ovary batch x treatment and the effect of time was
tested using ovary batch x time. The effect of treatment x time was tested using ovary
batch x treatment x time, and the remaining terms were tested with the residual.
Results
Experiment 1
Photomicrographs (40x) of bovine granulosa cells following 8-days of in vitro
culture in medium supplemented with different substitutes are depicted in Figures 1.3
through 1.5. Morphological characteristics of cells cultured in this study were similar
to those reported by Savion et al. (1981a). In the present study, cells cultured in basal
medium alone tended to become flattened and enlarged. Trypan blue exclusion staining
performed on cells at each count also indicated low cell viability by day 6 of culture
(data not shown). Those cells cultured in either FBS, FAF-BSA or SerXtend appeared
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Figure 1.3. A photomicrograph (40X) of bovine granulosa cells that were initially
seeded (5 x 105 cells/flask) in medium containing 10% FBS for 48 hours. The
photograph was made following 8 days of treatment culture in medium alone.
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Figure 1.4. A photomicrograph (40X) of bovine granulosa cells that were initially seeded
(5 x 10s cells/flask) in medium containing 10% FBS for 48 hours. Pictures were taken
following 8 days of treatment culture in medium containing 1% FBS (top) or 1 % GMSX
(below).
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Figure 1.5. A photomicrograph (40X) of bovine granulosa cells following 8-days of
serum-free culture in medium containing either 4 mg/ml FAF-BSA (top) or 5 %
SerXtend (below).
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healthy, maintained an "epithelial-like" appearance and were > 85 % viable on day 8
of culture. Cells cultured in these treatments formed small, tightly bound colonies from
which they continued to proliferate until confluency. However, the cells cultured in
GMSX appeared to take on a "fibroblast-like" appearance, exhibiting signs of
elongation and a low nuclear to cytoplasmic ratio.
The initial seeding of bovine granulosa cells in medium supplemented with 10%
FBS provided attachment and subsequent proliferation for all treatment media except
the control. Cell populations during days 1 to 8 of culture in different treatment media
are demonstrated in Figure 1.6. The basal mixture of DMEM/F-12 (Control) did not
enhance cell proliferation. The addition of calf serum or FAF-BSA to the medium
provided an increase (P c.01) in cell numbers through day 4 when compared with
granulosa cells cultured in the control medium, while a significant decline (P < .05) in
cell numbers followed confluency at day 4.
Treatment 3 (GMSX) also produced higher (P < .001) cell numbers compared
with the control group through confluency (day 4 of treatment culture), followed by a
rapid decline by day 6 and a slight, nonsignificant increase on day 8 of culture. The
number of cells/flask was greater in Treatment 3 on day 2 and 4 of the culture period
when compared with both the Treatment 2 (P < .01) and Treatment 4 (P < .01) and was
greater (P < .001) than the control treatment on day 8. The SerXtend (Treatment 5)
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Figure 1.6. Proliferation (+SEM) by granulosa cells cultured in basal medium alone
or medium containing FBS (1%), GMS-X (1%), FAF-BSA (4 mg/ml) or SerXtend
(5%) following an initial seeding period of 48 hours and an initial seeding rate of 5 x
105.
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produced the highest proliferation rate.

Cell numbers in this group were greater

(P < .001) than all other treatments and there was no decline following confluency.
The steroidogenic capability of bovine granulosa cells in extended serum-free
culture was evaluated by determining the amount of progesterone present in the media
at 2-day intervals (Figure 1.7).

Progesterone concentrations are reported on a

normalized basis as ng of progesterone/100,000 viable cells. On days 1 and 2 of
treatment culture, Treatments 1, 2, 3 and 4 produced greater (P < .001) concentrations
of progesterone when compared with those of Treatment 5. On day 4 of treatment
culture, granulosa cells in Treatment 4 produced more (P c .0 5 ) progesterone than
Treatment 1, 3 and 5 but was not different from Treatment 2.
The bovine granulosa cells in Treatments 1 and 5 produced the least amount of
progesterone. The ranking trend in progesterone production was similar for days 6 and
8, with Treatments 2, 3 and 4 producing more (P < .001) progesterone than Treatments
1 and 5. Overall, progesterone production by cells in all treatments was elevated
beginning on day 4 of culture; however, progesterone secretion by granulosa cells
cultured in Treatments 2, 3 and 4 remained significantly higher (P<.01) than
Treatments 1 and 5 throughout the remaining culture period.
Experiment 2
Experimental conditions for Experiment 2 also provided for cell proliferation
for each SerXtend medium concentration evaluated (Figure 1.8). There were no
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Figure 1.7. Progesterone production (±SEM) by granulosa cells cultured in different
treatment media in Experiment 1. Progesterone concentrations were normalized on a
number of viable cells/ng of progesterone (10'3) basis. Bars within days with different
letters differ as indicated in the Results text section.
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Figure 1.8. Proliferation (±SEM) by granulosa cells cultured in basal medium or basal
medium containing 5%, 2.5%, 1.25% or .625% SerXtend following an initial seeding
period of 48 hours and an initial seeding rate of 5 x 10s.
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difference in cell proliferation rates between SerXtend treatments at each evaluation
time.

Bovine granulosa cell proliferation was greater (PC.Ql) in the SerXtend

treatments (2 through 5) when compared with the controls on days 1, 2, 4 and 6, but
proliferation of these groups was not significantly different from the control group on
day 8 of culture. For each treatment, cell confluency was reached at approximately day
4 o f treatment culture, after which cell numbers declined. Cell numbers remained
consistently low in the control treatment during the 8-day evaluation period, indicating
that the culture medium alone was not capable of stimulating the granulosa cells into
mitotic division.
On days 1 and 2 of culture, the cells in the control group produced a higher
(P < .05) concentration of progesterone when compared with the SerXtend treatments
(Figure 1.9). However, on day 6 of culture, progesterone secretion was significantly
higher (PC.01) in the SerXtend Treatments 3, 4 and 5 (2.5 %, 1.25% and .625 %
SerXtend, respecitvely).

Also, progesterone production by SerXtend-treated cells

gradually increased during the culture period, and was significantly greater for each
SerXtend treatment when compared with the control treatment (medium alone) on day
8 o f treatment culture.
Figure 1.10 represents the proliferation of cells that were seeded at a rate of 2.5
x 105 cells/25-cm2 flask and cultured in medium containing 10% serum during the
initial 24 hour seeding period. As expected, cells cultured in the control medium alone
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Figure 1.9. Progesterone production (±SEM) by granulosa cells cultured in different
concentrations of SerXtend in Experiment 2. Progesterone concentrations were
normalized on a number of viable cells/ng of progesterone (10'3) basis. Bars within
days with different letters differ as indicated in the Results text section.
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Figure 1.10. Proliferation (±SEM) by granulosa cells cultured in basal medium, or
basal medium containing 2.5%, 1.25%, .625%, .3125% or .078% SerXtend following
an initial seeding period of 24 hours and an initial seeding rate of 2.5 x 105.
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did not increase in number. However, when cultured in medium containing .3125%
or greater SerXtend, granulosa cell populations gradually increased beginning on day
4 and continuing through day 8 of treatment culture. Treatments 2 and 3 produced a
significantly higher (P< .001) number of cells when compared with Treatments 4, 5
and 6 on day 6 of treatment culture. On day 8 of treatment culture, Treatment 2
produced a higher (P < .001) number of cells than Treatment 5 but was not greater than
Treatments 3 and 4. Proliferation rates of granulosa cells cultured in Treatment 6
medium did not differ from the control group (medium alone).
Discussion
These experiments demonstrate that granulosa cells can be cultivated in a serumfree culture system. The basal medium was able to maintain the majority of cells that
had attached during the initial serum seeding period for up to 8 days in culture, as was
previously reported for granulosa cells cultured in Hams F-12 medium (Skinner and
Osteen, 1988).

In contrast, both the FBS and FAF-BSA induced granulosa cell

proliferation at approximately the same rate. These data are in agreement with those
of Borano and Hammond (1985) who noted similar proliferations rates of bovine
granulosa cells between FBS and FAF-BSA.
Removal of serum from granulosa cell cultures (control) resulted in a significant
decline in progesterone production over the culture interval (Figures 1.7 and 1.9). In
comparison, progesterone production by cells cultured in FBS- or FAF-BSA-
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supplemented media increased from days 4 to 6 of culture and was maintained at day
8. Progesterone concentrations for the FBS- and FAF-BSA-supplemented treatments
were significantly greater than in control culture at these sampling periods. Therefore,
serum and its albumin constituent, may mask the effects of luteotropic agents added to
the medium in nonproliferative cells (control) during the 6 to 8 day culture period
following serum removal. However, the high proliferative capacity of granulosa cells
grown in medium containing SerXtend appears to override the ability of the cells to
produce progesterone immediately following serum removal. Therefore, if granulosa
cells are grown to confluency using medium containing the SerXtend, regulatory agents
may be added following a relatively short equilibration period in a maintenance
medium.
Differences in cell proliferation rates may offer a possible explanation for the
high progesterone production observed in the control group versus the low production
by SerXtend treated cells. Progesterone production by cells incubated in the SerXtend
treatment (Figure 1.7) was inversely related to cell numbers (Figure 1.6). When
mitogenic activity was high (days 1 through 4), progesterone production was low, and
when proliferation rates were low (days 6 and 8), progesterone production was
increased. This inverse relationship between proliferation and steroidogenesis has been
reported for bovine granulosa cells (Orly et al., 1980; Erickson, 1983; Meidan et al.,
1990). These data, along with other results from our laboratory, indicate that granulosa
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cells cultured in extended serum-free environments for up to 8 days are capable of
secreting progesterone upon subsequent stimulation.
The stimulation of progesterone production by nonproliferating cells in the
SerXtend treatment, during the latter stages of culture, may be a function of the insulin
contained in the SerXtend preparation. Mitogenic and steroidogenic effects of insulin
have been reported for bovine (Savion et al., 1981a; Langhout et al., 1991; Spicer et
al., 1993), porcine (Borano and Hammond, 1985; May et al., 1988) and primate
(Woodruff et al., 1993) granulosa cells in serum-free culture systems. Langhout et al.
(1991) reported an increase in cell proliferation and steroidogenesis by bovine granulosa
cells collected from both small and large follicles. The mitogenic effects of insulin
have been associated with its affinity for the IGFl receptors, as opposed to direct action
through its own receptor (May and Schomberg, 1981; Savion et al., 1981a).
In our study, the medium supplement (GMS-X, consisting of insulin, selenium,
transferrin and ethanolamine) adequately supported granulosa cell proliferation but
produced levels of progesterone similar to that of FBS. This phenomenon has been
reported by other investigators (Veldhuis et al., 1985; Langhout et al., 1991; Spicer et
al., 1993), and may be considered a problem in studies involving hormonal regulation
of follicular enzymes.

Progesterone secretion stimulated by serum-supplemented

culture media may mask some effects of added regulatory agents, such as forskolin or
cAMP, when studying the regulation of the P450scc enzyme (Skinner and Osteen,
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1988; Meidan et al., 1990). Similarly, serum constituents have been reported to induce
prostaglandin formation by activation of the COX enzyme (Mitchell and Trautman,
1993).
The SerXtend used in this study is classified as a serum substitute containing
less than 50 mg/ml of protein. According to the manufacturers recommendations, 12.5
ml of SerXtend should be added to 500 ml of serum, which in turn reduces the amount
of serum needed in the culture medium. However, in the present study, SerXtend alone
was added to the media without the addition of serum. SerXtend is reported to contain
FGF, EGF, insulin, BSA, transferrin, ethanolamine, thioctic acid, selenium and
hydrocortisone. This substitute was studied because of the observation by Savion et
al. (1981a) that EGF and FGF alone did not produce a mitogenic effect in vitro, but
when combined with insulin, these growth factors increased cell proliferation over that
of insulin alone. In our study, the SerXtend milieu also produced a mitogenic effect
greater than the insulin treatment (GMS-X).
When cells were seeded at an initial rate of 5 x 10s, cell confluency was reached
between days 2 and 4 of the culture interval for the SerXtend treatment. In contrast,
when granulosa cells were seeded at a lower rate (2.5 x 10s), they tended to proliferate
in a moderate rate during the first 4 days of treatment culture, and were slower to reach
confluency; however, their cell number increased by the 6th and 8th day of culture.
In a previous report, granulosa cells originally seeded in FBS and then cultured on a
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plastic substratum in serum-free medium containing FGF and high density lipids did not
proliferate (Savion et al., 1981a). However, in this study, insulin-containing medium
was able to induce proliferation when cells were seeded at low concentrations.
Apparently, cell-to-cell contact is the limiting factor in the proliferation of granulosa
cells in serum-free media when no collagen matrix is utilized.
Currently, the most effective methods to culture bovine granulosa cells require
the addition of serum to the culture medium, which often produces variable responses.
A commercially-prepared serum substitute (SerXtend) was able to stimulate bovine
granulosa cell proliferation in culture for up to 8 days without significant loss of
cellular integrity as determined by the trypan blue dye exclusion method. Moreover,
when performing hormonal regulation studies, it may be beneficial to use SerXtend to
avoid triggering steroid synthesis during the proliferative stages of culture. This ability
to grow granulosa cells from small follicles may, in the future, enhance our
understanding of granulosa cell growth and differentiation. The use of this serum
substitute may allow for the determination of the causative factors involved in granulosa
cell proliferation and steroidogenesis and their specific mechanisms during
folliculogenesis.
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CHAPTER n
CORTICOSTERONE REGULATES PROSTAGLANDIN FORMATION BY
FORSKOLIN STIMULATED BOVINE MURAL GRANULOSA CELLS
FOLLOWING EXTENDED SERUM-FREE CULTURE
Introduction
The most efficient methods of increasing cell numbers in vitro involves the use
of serum-supplemented culture medium. However, the interpretation of results from
experiments dealing with hormonally-regulated enzymes is complicated by the addition
of serum to the culture medium (Orly et al., 1980; Erickson, 1983). This is due to an
undefined mixture of hormones, nutrients and growth and attachment factors that
serum contains (Savion et al., 1981).
Studies involving the effects of serum supplementation on granulosa cell
function demonstrate that serum constituents alone are capable of inducing
steroidogenesis, while masking the effects of exogenous regulatory agents, such as
forskolin and LH (Savion et al., 1981; Skinner and Osteen, 1988; Meidan et al., 1990).
However, Broussard et al. (1995) noted that a commercially-prepared serum substitute
was able to promote bovine granulosa cell proliferation, while minimizing steroido
genesis. The mitogenic potential of this serum substitute enabled the production of
large number of cells through in vitro culture, allowing low numbers of granulosa cells
to be increased prior to the addition of regulatory agents, such as forskolin or
corticosterone.

68
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Espey (1980) proposed a general model for mammalian ovulation, which
included the accumulation of prostaglandins in the liquor folliculi near the time of
ovulation. The exact mechanism of prostaglandin-induced ovulation is not known;
however, the ecosinoids are thought to have a variety of local functions in the
preovulatory follicle, including fibroblast proliferation, chemotaxis, vasodilation and
destruction of connective tissue (for review see Espey, 1980, 1994). Several reports
implicate COX-2 (the inducible isoform of the cyclooxygenase enzyme) in the rapid
formation of the cyclooxygenase prostaglandins in the rat preovulatory follicle (Sirois
and Richards, 1992; Sirois et al., 1992) following stimulation by hCG near the time of
ovulation. More recently, the COX-2 isozyme was found to be present in the granulosa
cells of hCG stimulated preovulatory follicles of the cow (Sirois, 1994).
Therefore, a preliminary and two primary experiments were designed to
determine if bovine granulosa cells cultured in a serum-free in vitro environment were
able to respond to the regulatory agent, forskolin, an adenylate cyclase activator that
has been reported to mirror in vivo LH activity (Meidan et al., 1992), by producing
progesterone and prostaglandins. The primary objective of the study was to establish
if the COX isozyme is responsible for prostaglandin formation by forskolin stimulated,
in vitro cultured granulosa cells. Corticosterone, which specifically inhibits COX-2
prostaglandin formation (Lee et al., 1992), was added to the culture medium to
distinguish between the function of COX-1 and COX-2 in this prostaglandin formation.
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Materials and Methods
Culture Medium and Supplements
The basal medium, Dulbecco's modified Eagle medium/Hams F-12 nutrient
mixture (DMEM/F-12; 1:1 v/v), and GMS-X* (GMS-X; a medium supplement
containing 1 g/L insulin, .67 mg/L sodium selenite, .55 g/L transferrin and .2 g/L
ethanolamine), fetal bovine serum (FBS), penicillin and streptomycin were purchased
from Gibco Laboratories (Grand Island, NY).

Arachidonic acid and hydrocorti

costerone were purchased from Sigma Chemical (St. Louis, MO). The SerXtend*
(SerXtend; a serum substitute reported by the manufacturers to contain fibroblast
growth factor (FGF; bovine), epidermal growth factor (EGF; murine), insulin, BSA,
transferrin (pasteurized human), ethanolamine, thioctic acid, selenium and hydro
cortisone (< 5 0 mg/ml protein) was supplied by Irvine Scientific (Santa Ana, CA).
Granulosa Cell Isolation
Ovaries from mixed breed beef cows of unknown origin were collected from a
local abattoir in warm PBS containing antibiotics and transferred to the laboratory
within 5 hours.

A single cell suspension of granulosa cells was obtained by aspirating

2- to 8-mm diameter follicles, as previously described by Broussard et al. (1995).
Briefly, the follicular aspirates were dispensed into 15-ml polypropylene conical
centrifuge tubes that were incubated at room temperature for 15 minutes to allow for
sedimentation of cumulus oocyte complexes and aggregated granulosa cells.
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follicular fluid was aspirated and the cells washed three times with 10 ml of DMEM/F12 containing 10% FBS, 100 units penicillin and 100 ^g/ml of streptomycin (seeding
medium) by centrifugation at 200 x g for 10 minutes at 20°C. The cells were then
resuspended in 10 ml of seeding medium, and the number of viable cells determined
(Freshney, 1987).
Culture Phases
For each experiment described herein, the granulosa cell culture was split into
three separate phases including a seeding, a proliferative, and an experimental phase
(see Figure 2.1). The seeding and proliferative phases were utilized to produce large
cell numbers for the experimental phase and were performed as previoulsy described
(Broussard et al., 1995) in a similar manner for all experiments. For the initial seeding
phase, 2.5 x 10s viable cells were pipetted into duplicate sets of 25-cm2 tissue culture
flasks (Costar; Cambridge, MA) containing 5 ml of seeding medium. Cells were
allowed to attach to the substratum for 24 hours in seeding medium and then washed
once with 2 ml of basal medium. Once seeded, the granulosa cells were washed once
with 2 ml of basal medium, and then 5 ml of basal medium containing SerXtend (1 %
v/v) was dispensed into the duplicate sets of flasks. This proliferative phase consisted
of a 6 day granulosa cell culture in SerXtend to allow for granulosa cell proliferation
to confluence, followed by a wash with 2 ml of basal medium and a 1-day equilibration
period with basal medium containing 1% v/v GMSX (GMSX medium; five ml/flask).
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Figure 2.1. A schematic drawing of the experimental design for Experiment 1. The abbreviations "FBS" represents fetal
bovine serum, "GMSX" represents GMSX medium, "Foisk" represents forskolin, "h" represents hour and "AA represents
arachidonic acid.
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Medium was changed every other day during the proliferation phase, and all cultures
were maintained at 39°C in an atmosphere of 95% air and 5 % C 02.
Preliminary Experiment
The objective of the Preliminary Experiment was to determine if bovine
granulosa cells respond to the regulatory agent, forskolin, following 6 days of serumffee culture by secreting progesterone into the medium. Flasks (n = 72, 6 treatments
x 4 sampling periods x 3 replicates) containing a confluent monolayer of granulosa cells
were randomly allotted to one of six treatment media consisting of 5 ml of basal
medium alone (Treatment 1, negative control) or basal medium containing forskolin
(Treatment 2), 1% FBS (Treatment 3; positive control), 1% FBS plus forskolin
(Treatment 4), GMSX medium (Treatment 5) and GMSX medium plus forskolin
(Treatment 6). All treatment media that contained forskolin (Treatments 2, 4 and 6)
did so at a 10 uM concentration. The treatment culture persisted for 6 days, with
medium changes and sampling times occurring on days 1, 2, 4 and 6 of treatment
culture.
Experiment 1
The specific objective of Experiment 1 was to determine if in vitro cultured
bovine granulosa cells were capable of producing prostaglandin F2« in response to
forskolin stimulation at the time previously determined to occur in in vivo preovulatory
follicles (Sirois, 1994). A duplicate set of 25 cm2 flasks (n = 36; 3 treatments x 4
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sampling periods x 3 replicates) were grown to confluency as described in the Culture
Phase section.

The experimental phase began immediately following the 1-day

equilibration period, and was designated as Time 0 (hour) for the experimental phase
(see Figure 2.1).
Granulosa cells cultured in the control treatment (Treatment 1; see Figure 2 .1A)
remained in GMSX medium for the remainder of the culture period (24 hours).
Granulosa cells cultured in Treatment 2 medium (see Figure 2. IB) were incubated in
GMSX medium 16 hours (beginning from Time 0), at which time the flasks were
washed once with 2 ml of basal medium and replaced with 5-ml of GMSX medium
plus arachidonic acid (10

mM)

was added.

For Treatment 3 (see Figure 2.1C),

granulosa cells were exposed to a 5 hour incubation period (beginning at Time 0) with
GMSX medium plus forskolin (10 ^M). Flasks were then washed once with 2 ml of
basal medium and the granulosa cells were then cultured for 11 hours in GMSX
medium. At hour 16, flasks in Treatment 3 were again washed once with 2 ml basal
medium that was replaced with GMSX medium plus arachidonic acid (10 ^M). For
Treatments 1 and 2, GMSX medium was removed from the flasks 5 hours following
the initiation of the experimental phase and replaced with 5 ml of fresh GMSX medium
to remain consistent with medium changes in Treatment 3.
The medium was harvested at 2-hour intervals during the sampling period (18,
20, 22 and 24 hours post-initiatior! of the experimental phase) and frozen at -80° C until
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later assay for prostaglandin F2a . During the experimental phase, all flasks contained
5 ml of treatment medium, which was removed from each treatment flask at each
sampling period and replaced with fresh culture medium appropriate to that treatment.
Culture medium was not replaced in treatment flasks on days 1 and 8 of treatment
culture.
Experiment 2
The objective of Experiment 2 was to determine if corticosterone, which
selectively inhibits prostaglandin formation by the COX-2 isozyme was capable of
inhibiting prostaglandin secretion by forskolin-stimulated granulosa cells.

The

experimental phase (n = 36 flasks; 4 treatments x 3 sample periods x 3 replicates) for
Treatment 1 (control) and Treatment 2 in Experiment 2 were identical to Treatments
1 and 3 in Experiment 1, respectively. The experimental phase for Treatments 3 and
4 in Experiment 2 was identical to Treatment 3 in Experiment 1, except corticosterone
(1

and 10 mM, respectively) was added 16 hours into the experimental phase, along

with arachidonic acid.
Media were harvested at 2-hour intervals during the sampling period (18, 20 and
22 hours of the experimental phase) and frozen at -80°C until assayed for prostaglandin
F2a . During the experimental phase, all flasks contained 5 ml of treatment medium,
which was removed from each treatment flask at each sampling period and replaced
with fresh medium appropriate to that treatment.
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Progesterone and Prostaglandin F2a Determination
Progesterone values for the Preliminary Experiment were analyzed using a
radioummunoassay previously validated by Thompson et al. (1983). The RIA was
performed in duplicate with appropriate standards. Standards were extracted with
petroleum ether prior to RIA analysis. The progesterone antibody used cross reacts
with

pregnenolone

(.5%),

estrone

( < .01%),

testosterone

(<.01% )

and

androstenedione (.04%). Each medium sample was diluted 50-fold prior to the assay,
with a 50-^1 volume of sample added to each tube. The percent recovery and binding
of [3H] progesterone was 75% and 38%, respectively.
Prostaglandin F2a values were obtained using an enzyme immunoassay kit
originating from Cayman Chemical (Ann Arbor, MI). The assay was performed in
accordance with the protocols that accompanied the kits.

According to the

manufacturer the prostaglandin F2a antibody has a cross reactivity of 100 % with
prostaglandin F2a, F,a and F3a; 7% with 6-keto prostaglandin F ta; <.5% with
prostaglandin A3 ; .3% with 2,3-dinor-6-keto prostaglandin F,a and <.1% with
prostaglandin Ej, 6 ,15-dideto-13,14-dihydro prostaglandin Fia, thromboxane Bj and
prostaglandin Ej. Media samples were added to the 96-well plates precoated with
murine monoclonal antibody at a volume of 50 (A, and the plates read at 412 nm.
Values for both progesterone and prostaglandin F2o were obtained in a single assay,
with an intra-assay coefficient of sl3 %.
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Statistical Analysis
For the Preliminary Experiment and Experiments 1 and 2, granulosa cells from
one group of ovaries were randomly divided into three replicates for each treatment and
sampling time (n=3 replicates/treatment/time period). Progesterone and prostaglandin
F2cc concentrations

in the medium were analyzed using least square analysis of variance

and the PROC GLM procedure of SAS (1985). If the differences between treatments
were significant, the PDIFF procedure of SAS was used for mean comparisons. Data
were analyzed using the model components of treatment, replicate (treatment), time,
treatment x time and residual. The effect of treatment was tested using treatment x time
and the effect of time was tested using replicate (treatment), and the remaining terms
were tested with the residual.
Results
Preliminary Experiment
Results from the Preliminary Experiment indicate that bovine granulosa cells
were capable of responding to forskolin by secreting progesterone in vitro (Figure 2.2).
Granulosa cells cultured in the control and control plus forskolin treatments did not
differ in mean progesterone production on days 1, 2 and 4 of incubation. Mean
progesterone production was significantly increased (P< .01) from cells cultured in FBS
plus forskolin when compared with cells cultured in FBS alone at all sample periods
evaluated. A similar significant increase was noted for cells cultured in GMSX medium
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Figure 2.2. Mean progesterone production (+SEM) by bovine granulosa cells
following a seven day serum-free culture period. Letters within each treatment day
represent a significant difference of at least P < .001.
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when compared with GMSX medium plus forskolin treatment on days 2 and 4 of
culture. However, progesterone production was not different between the two GMSX
medium treatments on days 1 and 6 of culture. Progesterone production was not
different among the control treatment (Treatment 1) and the FBS and GMSX treatments
(Treatments 3 and 5) at all sampling periods.
Experiment 1
Granulosa cells cultured in the control medium secreted the least amount of
prostaglandin F2a into the culture medium (Figure 2.3). The addition of arachidonic
acid to the medium during the experimental phase (Treatment 2) resulted in a
numerically higher (P > .05) secretion of prostaglandin F2a than cells cultured in the
control medium. However, those cells treated with forskolin and arachidonic acid
(Treatment 3) secreted much larger amounts (P< .0001) of prostaglandin F2a into the
medium than the control or the arachidonic acid treated cells at the 18, 20, 22 hour
sampling periods. Cells in Treatment 3 also secreted significantly more (P C .05)
prostaglandin F2a at the 24 hour sampling period when compared with control and
Treatment 2 concentrations.
Experiment 2
Granulosa cells in the control (Treatment 1) and forskolin plus arachidonic acid
(Treatment 2) treatments secreted concentrations of prostaglandin F2a into the medium
at a rate similar to their respective secretions in Experiment 1 (Figure 2.4). Granulosa
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cells in Treatment 2 secreted significantly more (P < .0001) prostaglandin F2a than the
control group at each sampling period evaluated.

The addition of 1

mM

of

corticosterone to the culture medium decreased prostaglandin F2a secretion at 18
(P < .001) and 20 (P < .05) hours after the cells were exposed to forskolin treatment.
There was no difference (P=.06) in prostaglandin F2o secretion between Treatments
2 and 3 at the 22 hour sampling period. However, when 10

of corticosterone

(Treatment 4) was added to the medium, prostaglandin F2a secretion by the granulosa
cells was significantly decreased (P<.0001) to levels similar to the control group
(Treatment 1) at all time periods.
Discussion
It would be of great benefit to be able to cultivate bovine granulosa cells in a
serum-free environment. This is especially true since FBS alone has been noted to
stimulate hormonally regulated enzymes, such as the P450 side chain cleavage enzyme
in the production of progesterone (Savion et al., 1981; Skinner and Osteen, 1988) and
the COX enzyme in the production of prostaglandins (Lee et al., 1992; Mitchell and
Trautman, 1993). In a Preliminary Experiment, forskolin significantly increased
progesterone production by granulosa cells that had previously been cultivated in a
serum-free environment. Progesterone secretion by granulosa cells was significantly
greater when stimulated by forskolin in the FBS- and GMSX-based medium when
compared with nonstimulated counterparts (Treatments 3 and 5, respectively) on days
2 and 4 of treatment culture. These data indicate that cultivation in a serum-free
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environment does not adversely affect the ability of bovine granulosa cells to respond
to a potent regulatory agent, forskolin.
Forskolin was utilized in the current study because of it has been reported to
mimic gonadotropin activity in bovine granulosa cells (Meidan et al., 1990; 1992).
Results of Experiment 1 results indicated that forskolin-stimulated prostaglandin F2a
secretion from granulosa cells cultivated in a manner similar those in the Preliminary
Experiment was increased when compared with the control treatment.

The

prostaglandin F2a precursor (arachidonic acid) , added to ensure it's availability to the
cells, did not stimulate prostaglandin F2a secretion above control levels, and was
significantly less than the forskolin stimulated cells.
These results are in agreement with in vivo studies performed in the rat (Sirois
and Richards, 1992; Sirois et al., 1992) and indicate that compounds having luteinizing
hormone-like activity stimulate prostaglandin F2a formation in bovine granulosa cells.
More specifically, bovine granulosa cells harvested from small follicles and grown in
a serum-free, in vitro environment were able to produce prostaglandin F2a at time
periods similar to those noted to occur in in vivo preovulatory follicles (Sirois, 1994).
These previous findings, along with the results from the current study, lend credence
to the hypothesis that prostaglandin F2a plays a significant role in the process of
mammalian ovulation during the critical time period just preceeding the release of the
oocyte into the reproductive tract (see reviews by Espey, 1980; Murdoch et al., 1993).
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Results from Experiment 2 indirectly implicate COX-2 as being the isoform that
is responsible for the majority of prostaglandin F2e secretion by in vivo cultured,
forskolin-stimulated, bovine granulosa cells. Prior to the characterization of COX-2,
studies indicated that gluccocorticoids and/or dexamethasone suppress prostaglandin
formation in endotoxin stimulated human mononuclear cells (Seibert et al., 1990) and
interleukin 1 stimulated human dermal cells (Raz et al., 1989). More specifically, Lee
et al. (1992) determined that dexamethasone specifically inhibits COX-2 mRNA
production of prostaglandin in endotoxin-stimulated macrophages of the mouse, without
affecting COX-1 mRNA production. Therefore, the results of the current study suggest
that prostaglandin secretion by bovine granulosa cells is a function of COX-2 enzymatic
acitivity.
It is apparent that serum-free culture is a viable alternative to FBS supplemented
culture, at least in-so-far as the enzymes that regulate progesterone and prostaglandin
F2a are concerned. Also, the 7-day serum-free culture apparently allows for granulosa
cell maturation. Richards and Bogovich (1982) previously reported that granulosa cells
harvested from small antral follicles of the rat are incapable of producing prostaglandins
following LH stimulation. The ability to grow steroidogenically functional bovine
granulosa cells from small antral follicles may enhance our understanding of granulosa
cell growth and differentiation during the process of folliculogenesis. It also appears
that translation of COX-2 is the rate limiting process in determining the interval from
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the preovulatory surge in LH to ovulation, which is conserved across species. In the
future, a similar culture system may provide answers to other regulatory mechanisms
in different cell types.
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CHAPTER HI
THE PRESENCE OF A NOVEL CYCLOOXYGENASE ISOFORM IN THE
MURAL FOLLICULAR GRANULOSA CELLS OF FSH
STIMULATED WOMEN
Introduction
Cyclooxygenase is a rate limiting enzyme that catalyzes the conversion of
arachidonic acid to various prostaglandins (Sigal, 1991). The original COX isoform
has an approximate MW of 69,000 and 70,000 in the mouse (Hedin et al., 1987) and
bovine species (Sirois, 1994), respectively. Both proteins are translated from a 2.8 kb
mRNA transcript. There are reports in the literature describing the presence of a novel
COX (COX-2) isoform produced by in vitro cultured tracheal mucosal cells (Rosen et
al., 1989). This isoform has a MW of 72,000 and is translated from a 4.0 kb mRNA
(Rosen et al., 1989). A similar COX isoform has also been isolated in the bovine
(Sirois et al., 1994) and humans (Hla et al., 1994).
Cyclooxygenase has been shown to play an important role in prostaglandin
formation during mammalian ovulation, which has been compared to an inflammatory
response (Espey, 1980). The accumulation of prostaglandins in the follicular fluid in
humans is inhibited by the administration of the NSAID indomethacin (Killick and
Elstein, 1987), and has since been reported to inhibit production of both the COX-1 and
-2 iso forms (Meade et al., 1993). This inactivation of the cyclooxygenase enzyme
occurs by an irreversible acetylation of the Ser-530 position (DeWitt et al., 1990).
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The cDNA encoding this protein, has been cloned in human vascular endothelial
cells using polymerase chain reaction primers from the murine TSI10 sequence (Jones
et al., 1993).

Human COX-2 is translated from a 4.3 kb mRNA and has an

approximate MW of 72,000 (Jones et al., 1993). Hla and Neilson (1992) reported the
stimulation of prostaglandin secretion by cos-7 cells previously transfected with human
COX-2 cDNA. This increase was appreciably reduced following a 2 hour incubation
in medium containing dexamethasone.
Recent reports have demonstrated the presence of COX-2 in the granulosa cells
of preovulatory follicles of the rat (Sirois and Richards, 1992; Sirois et al., 1992).
Production of the COX-2 isoform was noted to occur 2 to 5 hours following the
administration of an ovulatory dose of hCG (Sirois and Richards, 1992). Also, the
mural granulosa cells of preovulatory follicles have been stimulated to transcribe COX2 mRNA and translate COX-2 protein following hCG administration in prostaglandin
F2a short-cycled cows (Sirois, 1994).
The current study was undertaken to determine if the COX-2 isoform is present
in human preovulatory follicles. This would be the first report implicating this novel
isoform in human ovulation. Granulosa cells were harvested from the ovaries of FSH
stimulated females by the use of transvaginal ultrasound guided aspiration, and the
COX cellular content determined by western blot analysis using a polyclonal antibody
that recognizes both the COX-1 and -2 isoforms.
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Materials and Methods
Materials
For the Stimulation protocol, the Pergonal* and Metrodin* used in this study
were purchased from Serono Laboratories, Randolf, MA, the leuprolide acetate
(Lupron*) from TAP Pharmaceuticals Inc., Deerfield, IL and the Pregnyl (hCG) was
purchased from Organon Inc., West Orange, NJ. The oocyte flushing medium, Human
Tubal Fluid Medium (HTF-HEPES) was purchased from Irvine Scientific, Inc., Santa
Ana, CA and the medium supplement Plasmanate* purchased from Miles, Inc., Elkhart,
ID.
FSH Stimulation
Female patients (n = 16) ranging from 29 to 41 years of age (average age ±SEM
= 35+.9) with nonendocrine reproductive deficiences were utilized in the study. The
reproductive anomalies persisting in these patients, or their spouses included ovarian
adhesions, tubal blockage and unexplained male factor. Patients were advised to notify
the clinic as to the initial day of menses (day 1 of the menstrual cycle), and plasma
estradiol concentrations were determined and an ultrasound examination performed to
ensure that there was no ovarian cystic condition.
Subjects were GnRH downregulated with a GnRH agonist (Lupron; 5 mg/ml)
prior to follicle stimulation. Females were administered daily injections of . 1 ml of
Lupron, begining on day 15 of the menstrual cycle, for 15 days followed by 9 days of
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.5 ml injections of Lupron. Subjects were administered (i.m.) an average of 3 ampules
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IU LH per ampule) per day for 9 days, beggining on the 20th day of Lupron therapy.
On day 9 of FSH stimulation, patients were administered a 10,000 IU i.m. injection of
hCG to initiate in vivo oocyte maturation.
Granulosa Cell Collection and Isolation
Ultrasonic examinations and follicle aspirations were conducted using an
Ultrasound System 4 (Advanced Technology Laboratories, Tempe, AZ) ultrasound
attached to a 7.5 MHz probe. Follicles with a diameter greater than 1 mm were
aspirated from individual patients under general anesthesia using a 16 guage needle
(O'Neil Aspiration and Irrigation Needle, Go Medical Industries Ltd, Subiaco, Western
Australia) to obtain oocytes for in vitro fertilization (IVF).
Follicles were lavaged 2 to 3 times with 1 ml of warm flushing medium (HTMHEPEA containing 10 % plasmanate) to increase the recovery rates of both the follicle
enclosed oocyte and the mural granulosa cells, and collected into a 15 ml conical
centrifuge tube (Becton Dickinson, Lincoln Park, NJ). The aspirate was then poured
into a 60-mm petri dish (Falcon; Becton Dickinson) and searched under a light
microscope for oocytes at 37°C in 5% C 0 2 using a portable IVF Chamber (TVF
Isolette, Hoffman Surgical Equipment Company, Conshocken, PA).
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Immediately following isolation of the human oocytes, the remaiming granulosa
cells were aspirated from the 60-mm oetri dish using a pastuer pippette, pooled for each
individual patient, and then dispensed into 2 ml epindorf centrifuge tubes (Brinkmann
Instrument Company, Westbury, NY).

Granulosa cells were washed once by

centrifugation at 800 x g for 7 minutes. The supernatant was removed from the
centrifuge tubes and discarded, and the granulosa cell pellet stored at -80°C for later
assay for COX content.
Western Blot Analysis
Protein extraction was performed as previously reported by Sirois and Richards
(1992). Granulosa cells were homogenized in a TED buffer (20 mM Tris, pH 8, 10
mM EDTA and . 1 mM DEDTC) containing 2 mM octyl glucoside and centrifuged at
30,000 x g for 1 hour at 4 °C. The crude pellets were then sonicated (8 sec/cycle, 3
cycles) in TED buffer containing 45 mM octyl glucoside and the sonicates centrifuged
at 100,000 x g for 60 minutes at 4 °C. The supernatant was harvested and stored at
-80°C until electrophoretic analysis. Protein concentration was determined by the
method of Bradford (1976).
Proteins (50 iug) present in solubilized cell extracts were resolved by one
dimensional sodium dodecyl sulfate-poly acrilamide gel electrophoresis (SDS-PAGE).
Proteins were electrophoretically transferred to nitrocellulose filters as previously
described (Sirois and Richards, 1992). Filters were incubated with antibody (9181) that
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recognizes both COX-1 and -2 isoforms previously diluted 1:10 in 10 mM Tris buffered
saline (pH = 7.5) containing 2 % nonfat dry milk. Polyclonal antibodies raised in
rabbits against purified ovine COX were affinity purified on a cyanogen bromideacitivated sepharose column using ovine COX as the ligand (Sirois and Richards,
1992). [125I] protein A (1 x 106 cpm/ml in tris buffered saline containing 2 % milk)
was used to visualize proteins. Filters were washed in Tris buffered saline containing
5% Tween and exposed to film at -80 °C (Kodak XAR-5, XRP, Eastman Kodak). For
quantitative purposes, protein blots for individual patients were separately and
arbitrarily rated by two individual technichians on a scale from 1 to 4 (1 = little to no
precipitation; 4 = high precipitation).
Plasma Estradiol Concentration
Plasma estradiol concentrations were obtained from the individual patient
samples collected prior to ultrasound-guided transvaginal aspiration.

Estradiol

concentrations were analyzed on a total estradiol and a follicle diameter basis for this
study. The four sequential plasma samples harvested and the corresponding ovarianfollicular sonagrams taken from each individual patient immediately prior to ultrasoundguided transvaginal aspriation were used in the analysis. Estradiol concentrations were
determined using a fully automated enzyme immunoassay procedure (Immulite*; Los
Angeles, CA) that had a reported working range of 20 to 2,000 pg/ml level of
detection.
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Statistical Analysis
Granulosa cells from 16 patients were harvested and frozen as a single unit.
Serum estradiol concentrations and follicle diameters were analyzed using least square
analysis of variance and the PROC GLM procedure of SAS (1985). If the differences
in estradiol concentration or follicle diameter among COX scores were significant, the
PDIFF procedure of SAS was used to the compare means. Data were analyzed using
model components of COX score, patient within COX score, day, COX score x day.
The main effect of COX score was tested using patient within COX score mean square
as the error term and the effect of day was tested using COX score x day mean square.
Results
To determine whether COX isoforms were present in preovulatory follicles,
protein extracts were prepared from granulosa cells isolated approximately 36 hours
following administration of an ovulatory dose of hCG. Proteins were analyzed by
immuno-blotting using a polyclonal antibody having specificities previously described
in rats (Sirois and Richards, 1992) and sheep (antibody No. 9181 recognizes both COX1 and COX-2 isoforms) (Wimsatt et al., 1993).
The immunoreactive protein appeared as a 52,000 mw band (Figure 3.1),
believed to correspond to a breakdown proteolytic fragment of COX-2 as explained by
Sirois and Richards (1992) in rat granulosa cells, Hla and Neilson (1992) in human
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umbilical vein endothelial cells and in bovine granulosa cells (Sirois et al., 1994). In
contrast, the antibody (No. 9181) did not recognize COX-1 in human granulosa cells.
Two of the 16 patient granulosa cell samples were recorded as having a minimal
COX score of 1 (Figure 3.1; lanes 1 and 8, from left to right). Two of the patient's
granulosa cells had a score of 2 (lanes 2 and 14), while four of the patient's granulosa
cells were awarded a score of 3 (lanes 3, 7, 11 and 15). There were eight granulosa
cell samples that were awarded a score of 4 (lanes 4, 5, 6, 9, 10, 12, 13, and 16).
Total estradiol concentrations, separated by COX score are represented in Figure
3.2. Gel bands classified as having a COX score of 1,2 or 3 had similar total plasma
estradiol concentration on days 5, 4, 3 and 2 before aspiration. The gel bands assigned
a COX score of 4 had significantly higher of plasma estradiol 4, 3 and 2 days before
transvaginal oocyte aspiration.
Average follicle diameter separated by COX score is represented in Figure 3.3.
Those gel bands having a COX score of 4 had significantly larger average follicle
diameter when compared with gel bands scoring 2 and 3, 5 days before aspiration.
There was no difference in follicle diameter among the different COX scores 4 days
prior to transvaginal aspiration. However, average follicle diameter was significantly
larger 3 days before transvaginal oocyte aspiration for gel bands rated as 4. There was
no difference in mean follicle diameter among the COX scores 2 days before
transvaginal aspiration.
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Figure 3.1. Western blot analysis for the presence of COX-2. Each lane of
the radiogram represents granulosa cells harvested from a single patient.
Solubilized extracts were prepared follicle granulosa cells as described in the
Materials and Methods section. Proteins (50 ^g/Iane) were analyzed by one
dimensional SDS-page and immunoblotting, using anti-COX antibody No.
9181 (see Sirois, 1994). Human blood platelets were run as a standard.
Markers on the left and right of patient lanes indicate the migration of
molecular weight standards.
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Discussion
Collectively, these results provide convincing evidence that the increased
prostaglandin secretion by mammalian follicles before ovulation (Espey, 1980) is
associated with the selective induction of COX-2 in granulosa cells. This study is the
first to establish that the granulosa cells of human preovulatory follicles are capable of
producing COX-2 following the administration of gonadotropins at ovulatory levels,
suggesting that the obligatory mechanism regulating the synthesis of prostaglandins is
conserved across the rat (Sirois and Richards, 1992), bovine (Sirois, 1994) and human
species. It is also important to note that antibody raised in rabbits against ovine COX
is capable of recognizing human COX-2 antigen.
Although the molecular weight of the COX-2 isoform differs from conventional
reports (Rosen et al., 1989; Xie et al., 1991), this phenomenon has been previously
reported. In cattle, Sirois (1994) described the presence of a second, lower mw band
of approximately 59,000 isolated from the granulosa cells of hCG stimulated bovine
preovulatory follicles. Similarly, Hla and Neilson (1992) noted the presence of a lower
mw protein (52,000) isolated from cos-7 cells transfected with cDNA of human COX2. Hla and Neilson (1992) suggested that the lower molecular weight protein may have
been translated from an incomplete mRNA fragment constructed during its
amplification via the polymerase chain reaction (PCR) methodology. However, both
laboratories also suggested that this lower mw protein is a breakdown product of the
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intact COX-2 protein. Since PCR technology was not employed during the study by
Sirois (1994) or in the present study, it is assumed this protein is indeed a breakdown
product of the intact COX-2 molecule.
Human chorionic gonadotropin has been reported to induce prostaglandin
formation in granulosa cells of the cow (Sirois, 1994), rat (Hedin et al., 1987; Sirois
and Richards, 1992) and human (Lumsden et al., 1986) preovulatory follicle.
However, one important difference in the regulation of rat vs human preovulatory
follicles is the distinct time course of COX-2 induction. Rat COX-2 mRNA and
protein are curtailed 9 hours after hCG treatment, while the induction of COX-2 protein
in human mural granulosa cells occurs later, being detected approximately 36 hours
following hCG administration. Although this difference appears suprising at first, it
should be expected that granulosa cells of rats and humans at comparable stages of
development (preovulatory) would produce prostaglandins at different times following
hCG administration due to the differing times of ovulation between the two species.
In the rat, the interval from time of hCG administration to ovulation is
approximately 14 to 16 hours (Sirois et al., 1992) compared with 38 to 42 hours
reported in humans (Lumsden et al., 1986). These observations may reveal one
mechanism regulating the normal duration of the ovulation process. Although it was
not possible to measure prostaglandin concentration in the human preovulatory follicles
aspirated in the present study, Lumsden et al. (1986) determined that prostaglandin F2a
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secretion by granulosa cells increases 36 hours following hCG administration. Also,
oocyte maturation appears to coincide with follicle maturation and prostaglandin F2«
production, since preovulatory follicle prostaglandin F2a production increases at the
same time the oocyte extrudes the first polar body in vivo (Seibel et al., 1984).
In summary, the identification of COX-2 as a novel, distinct isoform that is
present in the granulosa cells of hCG stimulated follicles offers new insight into the
regulatory mechanisms involved in human ovulation. This mechanism appears to have
been conserved across species, since similar COX-2 stimulation has been reported in
the rat (Sirois and Richards, 1992; Sirois et al., 1992) and bovine (Sirois, 1994)
species. This mechanism may be the regulatory process by which the length of the
ovulatory process is determined across species. These results may lead to in vitro
regulatory studies using serum-free culture methods (Broussard et al., 1995) to cultivate
human granulosa cells. The understanding of COX-2 production and regulation by
NSAIDS may improve our comprehension of the ovulatory process and their potential
role as a birth control method in humans (Killick and Elstein, 1987).
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CHAPTER IV
EFFECTS OF DEXAMETHASONE ADMINISTRATION TO DIESTRUS
COWS ON SYSTEMIC PROGESTERONE, ESTRADIOL AND
UTERINE CYCLOOXYGENASE PRODUCTION

Introduction
Prostaglandin H synthetase, also referred to as COX, is the initial rate limiting
enzyme in the prostaglandin, lipoxin and leukotreine synthesis pathways (Mitchell and
Trautman, 1993). Recent studies involving the regulatory mechanisms of prostaglandin
production have demonstrated the presence of two isoforms of the COX enzyme (Rosen
et al., 1989). Cyclooxygenase-1 (COX-1; mw ~ 70,000), the original isozyme isolated
from sheep vesicular glands (Miyamoto et al., 1976), is translated from a 2.8 kb
mRNA . Correspondingly, the COX-2 isozyme is translated from a 4.0 kb mRNA and
has a molecular weight of 72,000 (Kujubu et al., 1991; Xie et al., 1991).
Prior to the characterization of the COX-2 enzyme, dexamethasone reportedly
inhibited prostaglandin formation in endotoxin stimulated mice, but did not affect its
basal production (Masferrer et al., 1990). Similarly, cattle administered dexamethasone
intramuscularly exhibited an extended luteal phase that has been reported to be a
function of either decreased estrogen and preovulatory LH production (Vighio and
Liptrap, 1990) or by an inhibition of the production of enzymes that are necessary to
complete the COX pathway of eicosanoid production (Pool et al., 1983; Ingraham et
al., 1984). However, more recent studies indicate that dexamethasone selectively
104
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inhibits the inducible form of the COX-2 isozyme in mitogen stimulated macrophages
of mice (Masferrer et al., 1992) and rats (Lee et al., 1992).
The objectives of the current experiment were 1) to determine if the COX-2
isozyme is produced by the uterine endometrium during the luteolytic phase of the
bovine estrous cycle, and 2) to determine if dexamethasone extends the lifespan of the
corpus luteum by inhibiting the production of the COX-2 isozyme by the uterine
endometrium during the mid-luteal phase of the estrous cycle.
Materials and Methods
Treatment Allocation
Crossbred beef cows with a body condition score of 6 or greater (0 to 9) were
selected from the experimental physiology herd and maintained on native pasture at the
St. Gabriel Agricultural Research Station, St. Gabriel, Louisiana. Cows that exhibited
two previous estrous cycles ranging between 18.5 and 24 days were allotted to this
study. At the initiation of the experiment, cows were randomly assigned to treatments,
separated and maintained in .8-ha pastures, with pasture rotation performed as
necessary and minerals fed free choice.
Cows in the control group (n=4) were administered an intramuscular injection
of the treatment vehicle twice daily (0800 and 2000 h) on days 13 - 22 (estrus = day
0) of the treatment estrous cycle. Cows in the dexamethasone group (n=5) were
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similarly administered 8 mg of synthetic dexamethasone (Azium*) twice daily on days
13 through 22 of the treatment estrous cycle.
Blood Sampling
Blood samples were collected via venipuncture daily beginning on day 13 and
continuing through day 22 of the treatment cycle. Immediately prior to the morning
treatment injection, blood samples were harvested from the tail vein in vaccutainer
tubes containing heparin with a 20 gauge vaccutainer needle (Vacutainer®, Becton
Dickinson Co., Rutherford, NJ) and placed on ice.

The whole blood was then

centrifuged at 400 x g for 15 minutes, the plasma aspirated, and stored at -80°C until
assayed for progesterone and estradiol.
Hormone Analysis
Progesterone

values

were

obtained

using

a

previously

validated

radioummunoassay method (Thompson et al., 1983). Estradiol concentrations were
determined using commercial estradiol kits (Systems Diagnostic, Webster, TX). All
values for each steroid were obtained in a single assay, with an intra-assay coefficient
of variation of ^ 12.5 %.
Endometrial Sampling
Uterine endometrial biopsies were performed on cows assigned to both
treatment groups on days 16, 19 and 22 of the treatment estrous cycle.

On the

designated days following the morning treatment injection, individual cows were
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prepared for uterine biopsy by epidural injection of 5 ml of a 1% lidocaine solution
(W. A. Butler Company. Columbus. OH). The external genitalia were cleansed with
a betadine solution. A sterile biopsy instrument (Figure 4.1) was introduced through
the os cervix and endometrial samples were retrieved in the posterior portion of each
uterine horn on alternating collections days. Immediately following retrieval, endo
metrial tissue was freed from connective tissue, carefully blotted on soft tissue to
remove excess blood, dissected into 10 mg segments and frozen at -80°C until
subsequent protein assay and western blot analysis.
Western Blot Analysis
Protein extraction was performed as previously reported by Sirois and Richards,
1992. Uterine endometrial samples were homogenized using a TED buffer (20 mM
Tris, pH 8, 10 mM EDTA and . 1 mM DEDTC) containing 2 mM octyl glucoside and
centrifuged at 30,000 x g for 1 hour at 4°C. The crude pellets were then sonicated (8
sec/cycle, 3 cycles) in TED buffer containing 45 mM octyl glucoside and the sonicates
centrifuged at 100,000 x g for 60 minutes at 4°C. The supernatant was harvested and
stored at -80°C until electrophoretic analysis. Protein concentration was determined
by the method of Bradford (1976).
Western blot analysis using anti-COX antibody No. 9181, was performed as
previously described by Sirois (1994). Briefly, 50 Mg of total protein present in
solubilized cell extracts were resolved by one dimensional SDS-PAGE. Proteins were
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Figure 4.1. A photograph of the uterine biopsy instrument utilized to harvest uterine
endometrial samples on days 16, 19 and 22 of the treatment cycle.
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then electrophoretically transferred to nitrocellulose filters. Filters were incubated with
antibody (No. 9181) that recognizes both COX isoforms in the cow. Filters were
washed in Tris-buffered saline containing 5 % Tween and exposed to film at -80°C
(Kodak XAR-5, XRP, Eastman Kodak). Radiograms were then mounted on cardboard
backing and visually analyzed for the presence or absence of either COX.
Statistical Analysis
Progesterone and estradiol data were analyzed using a split-plot design with
repeated measures (Gill and Hafs, 1970). The model components included treatment,
cow(treatment), day, treatment by day and residual. Means were separated using the
PDIFF option of SAS.

Days to progesterone decline to < lng/ml, days from

progesterone decline to estrus and mean treatment cycle length were analyzed using a
one-way ANOVA.
Results
Mean estradiol concentrations for cows in the control and dexamethasone
treatments are represented in Figure 4.2. A peak in systemic estradiol was noted in the
control group on day 15 of the treatment cycle, which was significantly greater
(P < .01) than the dexamethasone treated cows. A significant rise (P < .01) in estradiol
was also noted in the control cows on days 20 to 22 of the treatment cycle when
compared with the levels in the dexamethasone-treated cows. Mean estradiol
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Figure 4.2. Mean estradiol concentrations (+SEM) for cows in the dexamethasone and
control treatments during the experimental estrous cycle.
Animals in the
dexamethasone group received 8 mg dexamethasone twice daily between days 13
through 22, while animals in the control group were treated with the vehicle alone.
The letter "a" indicates a significant difference between the two treatments (P < .01).
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concentrations in the dexamethasone-treated animals remained suppressed during the
treatment cycle, never again rising above 3 pg/ml.
Mean progesterone concentrations obtained during the treatment cycle for both
treatment groups are represented in Figure 4.3. Mean progesterone concentrations were
not different between the control and dexamethasone-treated cows on days 10 to 17 of
the treatment cycle. Circulating progesterone concentrations in the dexamethasone
treated group were significantly lower (P < .01) than the control cows on days 18 to 20
of the cycle. Circulating progesterone levels by the control cows declined on days 21
and 22 of the cycle and were not different from those circulating levels in the
dexamethasone treated cows.
There was no difference in the interval from estrus to progesterone decline to
< 1 ng/ml between the two treatment groups (Table 4.1). Mean intervals from the
onset of estrus to the time when progesterone declined to < lng/ml in the treatment
cycle for control and dexamethasone-treated animals were 21.3 and 19.4 days,
respectively (P< .01). However, the mean interval from progesterone decline to below
1 ng/ml during the diestrus phase of the treatment cycle to the post-treatment cycle
estrus was significantly greater (P< .01) for the dexamethasone-treated animals when
compared with control cows administered vehicle (11.6 and 2.6 days, respectively).
This notable increase in the interval from progesterone decline below 1 ng/ml to estrus.
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Figure 4.3. Mean progesterone (+SEM) production by dexamethasone and control
treated cows during the experimental estrous cycle. Animals in the dexamethasone
group received 8 mg dexamethasone twice daily between days 13 through 22, while
animals in the control group were treated with the vehicle alone. The letter "a"
indicates a significant difference between the two treatments (P < .01).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

113

Table 4.1. Effect of diestrous dexamethasone injections on the interval from estrus to
progesterone decline to < lng/ml, the interval from progesterone decline to < 1 ng/ml
to
estrus, and mean treatment cycle length.___________________________________
™-----------------Mean treatment
P4decline
P4 decline
< 1 ng/ml (day)
cycle length (days)
to estrus (days)
Treatment
-

-

Control

21.3±.3

2.6± .8a

24 ±3.5*

Dexamethasone

19.4±.9

11.6±1.6b

31± 2b

aP4 = progesterone.
b,cMeans within columns with different superscripts differ (P < .01).
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largely contributed to an extension (P < .01) in the overall mean treatment cycle length
in the dexamethasone-treated cows compared with the control group (31 versus 24 days,
respectively).
The western blot analysis indicated that the COX-2 isozyme was not present at
any time period evaluated in the uterine endometrial tissue sampled from cows in either
treatment group. Detectable levels of the COX-1 isozyme were noted in endometrial
tissue samples collected from both treatment groups at various stages of collection
(Figure 4.4). However, no discemable pattern was noted between the detection of
COX-1 and subsequent time of luteolysis in individual cows in either treatment.
Discussion
Parenteral administration of dexamethasone to diestrus cattle resulted in a
significant increase in estrous cycle length, as was previously reported (Pool et al.,
1983; Ingraham et al., 1984). Importantly, circulating progesterone profiles over the
treatment cycle indicate that this lengthening of the estrous cycle was not due to an
extension of corpus luteum function. Rather, the absence of an increase in circulating
levels of estradiol in dexamethasone treated animals tends to indicate that follicle
development was at least, in part, abated. This concept was further supported by the
fact that dexamethasone treated animals required an extended 12-day period to reinitiate
estrous cycle activity following luteolysis (progesterone < 1 ng/ml).
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Figure 4.4. Western blot analysis for the presence of the COX-1 Isozyme.
Numbers within treatment brackets indicate individual cows. Solubilized
extracts were prepared from uterine endometrium as described in the Materials
and Methods section. Proteins (40 /ug/lane) were analyzed by one-dimensional
SDS-pageand immunoblotting, using anti-COX antibody No. 9181 (see Sirois,
1994). Purified ovine prostaglandin G/H synthase (oPGS-1; 25 ng) was run as
a standard. Markers on the left indicate the migration of molecular weight
standards.
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Previous reports suggest that the administration of dexamethasone to diestrus
cattle affects the steroidogenic capabilities of both the growing follicle and the
regressing corpus luteum. In vivo, excessive systemic dexamethasone and/or ACTH
decreases gonadotropin secretion from the anterior pituitary (Johnson et al., 1982; Li
and Wagner, 1983). Vighio and Liptrap (1990) noted that both the frequency and
amplitude of LH pulses decrease with dexamethasone administration, thereby inhibiting
follicle development and estradiol production. However, basal production of LH was
not affected by dexamethasone production (Stoebel and Moberg, 1982; Vighio and
Liptrap, 1990).
Ingraham et al. (1984) found that dexamethasone injections to mid-luteal phase
heifers resulted in an extended corpus luteum lifespan over saline-treated heifers. It
was hypothesized by the authors that dexamethasone acts at the level of the uterus,
disallowing formation of the luteolytic substance prostaglandin F2a. These results, in
conjunction with those described (Johnson et al., 1982; Li and Wagner, 1983), suggest
that the ability of dexamethasone to extend the lifespan of the corpus luteum may be
two-fold. The first may be suppression of gonadotropin pulses mediated by the hypo
thalamus and, in turn follicle development (Johnson et al., 1982), which is necessary
for luteolysis to occur (Thatcher et al., 1986). It was suggested that pulsatile secretion
of gonadotropins would be adversely affected; however, basal LH secretion would not
be influenced, thus allowing for maintenance of the corpus luteum.
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A second method by which dexamethasone might increase the lifespan of the
corpus luteum is by inhibiting production of uterine Prostaglandin F2c, as previously
proposed in this laboratory (Ingraham et al., 1984). In the current study, it was
hypothesized that luteolysis is associated with the induction of uterine COX-2
production, and that dexamethasone treatment would decrease production of the COX-2
isozyme and the subsequent increase in prostaglandin F2a production that is usually
associated with luteal regression. This proved not to be the case.
Different physiological mechanisms have been proposed to regulate the expression
of the COX isozymes. The COX-1 isozyme is constitutively produced and believed to
be involved in the homeostatic regulation of prostaglandin formation for normal gastric
and vascular function (Dewitt et al., 1993). The COX-2 isozyme has been associated
with "immediate response" situations, in which prostaglandins must be produced at a
rapid rate in instances such as inflammation, ovulation (Dewitt et al., 1993), and
possibly luteolysis. Since dexamethasone has been shown to specifically suppress
production of the COX-2 isozyme in mitogen stimulated rats (Lee et al., 1992), it was
hypothesized that uterine endometrial COX-2 production by cows receiving
dexamethasone would be suppressed, while maintaining some level of COX-1
production. Conversely, in the absence of dexamethasone, the uterine endometrium of
the control cows was expected to produce some level of COX-2 during the luteolytic
phase of the bovine estrous cycle.
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The COX-1 isoform was produced sporadically throughout the sampling periods
by the uterine endometrium of cows in both the control and dexamethasone treatments.
In contrast, the COX-2 isozyme was not detected in either the control or dexameth
asone-treated cows. Sirois (1994) has reported the induction of the COX-2 isozyme in
the preovulatory follicles of cows treated with human chorionic gonadotropin.
However, in the preovulatory follicle, the kinetics of the COX-2 isozyme appear to be
quite rapid, with only a short window of production between 18 to 26 hours following
the human chorionic gonadotropin injection. In the present study, it is possible that the
sampling periods may have been too infrequent to detect production of COX-2 in the
uterine endometrium or that uterine COX-2 production is not involved in prostaglandin
formation during luteolysis.
In summary, our study suggests that the extension of the bovine estrous cycle by
daily injections of dexamethasone (days 13 through 22) is not dependant on an
extension of corpus luteum function, but rather on delayed or impaired preovulatory
follicle development, as evidenced from decreased circulating estradiol levels. Also,
this study does not support the working hypothesis that induction of COX-2 is involved
during luteolysis. However, we cannot exclude the possibility that the COX-2 isozyme
may be transiently expressed in the uterus at the time of luteolysis and that its lack of
detection in the present study could have resulted from infrequent sampling periods.
Currently, our laboratory is examining the possibility that the COX-2 isozyme converts
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arachidonic acid to prostaglandin in the corpus luteum itself, rather than in the bovine
uterine endometrium.
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CONCLUSIONS
For years there has been disputes on the mechanisms involved in mammalian
ovulation and luteolysis. The experiments conducted document the effectiveness of a
serum-free culture system as a tool to cultivate large numbers of bovine granulosa cells.
This is especially important since it is widely accepted that constituents of serum alone are
capable of inducing many cellular processes including steroidogenesis and prostaglandin
formation. This serum-free culture system allowed for further study into the effects of
Lhlike stimulation on prostaglandin F2a secretion by bovine follicular granulosa cells.
Experiments (Chapter II) that were conducted using this serum-free culture system
provided evidence that bovine granulosa cells are capable of producing large amounts of
prostaglandin following forskolin stimulation. It is important to note that mural granulosa
cells are capable of producing prostaglandin F2a at similar in vivo times. Prostaglandin
production was curtailed following the addition of dexamethasone to the medium,
implicating induction of the COX-2 enzyme in this process. Finally, the results of in vitro
studies (serum-free cultures of bovine granulosa cells with regulatory agents) closely
mimicked those observed in vivo, and thereby provide models for the study of the
molecular mechanisms of COX-2 gene expression.
By demonstrating that high levels of gonadotropins (hCG) are able to induce COX2 production by granulosa cells of human preovulatory follicles before ovulation, as in rats
and cows, the study performed in Chapter IH demonstrates that the expression o f COX-2
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is a mechanism that has been conserved across species. This mechanism may have been
preserved across species to regulate the synthesis of prostaglandins necessary for follicle
ovulation to occur.
Interestingly, a marked difference in the time course of induction of COX-2 in rats
and humans suggests that the control of COX-2 gene expression could play a pivotal role
in defining the normal length of the ovulatory process across species. Moreover, the acute
induction of COX-2 by gonadotropin in granulosa cells before ovulation remains a unique
physiological event, during which the molecular mechanisms of COX-2 regulation may be
readily studied in vivo or in vitro.
The exact mechanisms involved in the process of corpus luteum regression, which
occurs towards the latter stages of the bovine estrous cycle, still remains unresolved. The
current belief of the mechanisms involved with luteolysis in cattle still lie in the "old
school" train of thought that prostaglandin transverses the broad ligament to the ovary and
enclosed corpus luteum after being released from an estrogen primed uterus.

However,

the founding authors of the "counter current mechanism" themselves have since questioned
the true physiological relevance of this mechanism. Also, later studies have suggested that
there is no counter current exchange of prostaglandin from the uterine vein to the ovarian
artery.
Based on the results of the experiment performed in Chapter IV, it appears unlikely
that the COX-2 isoform is present in the cells of the uterine endometrium during the period
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of luteolysis. Tissue extracts obtained from the bovine uterus during the luteolytic phase
of the bovine estrous cycle indicate the absence of the COX-2 isoform at this critical time
period (days 16,19 and 22 of the bovine estrous cycle). Although the COX-1 isoform was
noted to be present during this period, no discemable pattern of its production could be
correlated with luteal regression in individual animals.
With the COX-2 isoform being recently discovered, it has been largely man
ipulated in unphysiological situations in attempts to quantify and classify its production.
These studies included situations where the COX-2 isozyme was studied in following
transfection into Swiss 3T3 and Cos-7 cells. It was the design o f the studies included
herein to provide a "physiological relevance" of this enzyme to certain reproductive
processes. Although such studies have been thought to do so, it is important that further
studies continue along these lines to help resolve the mechanisms involved in prostaglandin
synthesis and regulation in reproductive and other biological processes.
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